Authors
This author initiated 11 original pathways:
This author contributed to 1521 pathways:
This author contributed to 1521 pathways:
Eweitz
Eric Weitz
I refine pathways, and engineer them into tools for biological discovery.
My contributions are mostly systematic graphical and data improvements. Lately, I have created a number of new pathways, sourced directly from literature, PFOCR, and other pathway databases. The quick and open nature of WikiPathways is delightful.
I also incorporate pathways into Gene Leads Ideogram, a reuseable web component I've been developing to enrich gene search.
---
- GitHub: eweitz
Communities
Pathways
This author initiated 11 original pathways:
This author contributed to 1521 pathways:
This author contributed to 1521 pathways:
- FGFR4 p.G388R signaling - WP5428 (Homo sapiens)
- Estrogen metabolism - WP5276 (Homo sapiens)
- Synthesis of ceramides and 1-deoxyceramides - WP5194 (Homo sapiens)
- Biosynthesis and turnover of 1-deoxy-sphingoid bases - WP5179 (Homo sapiens)
- Docosahexaenoic acid oxylipin metabolism - WP5154 (Homo sapiens)
- N-glycan biosynthesis - WP5153 (Homo sapiens)
- Sialylation - WP5151 (Homo sapiens)
- Lipid metabolism in senescent cells - WP5149 (Homo sapiens)
- Interactions of natural killer cells in pancreatic cancer - WP5092 (Homo sapiens)
- Fluoroacetic acid toxicity - WP4966 (Homo sapiens)
- 16p11.2 proximal deletion syndrome - WP4949 (Homo sapiens)
- Major receptors targeted by epinephrine and norepinephrine - WP4589 (Homo sapiens)
- Metabolism of alpha-linolenic acid - WP4586 (Homo sapiens)
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
- Blood clotting and drug effects - WP4580 (Homo sapiens)
- Translation inhibitors in chronically activated PDGFRA cells - WP4566 (Homo sapiens)
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560 (Homo sapiens)
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559 (Homo sapiens)
- Genes related to primary cilium development (based on CRISPR) - WP4536 (Homo sapiens)
- Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms - WP4534 (Homo sapiens)
- Intraflagellar transport proteins binding to dynein - WP4532 (Homo sapiens)
- Cysteine and methionine catabolism - WP4504 (Homo sapiens)
- Signal transduction through IL1R - WP4496 (Homo sapiens)
- Ophthalmate biosynthesis in hepatocytes - WP4487 (Homo sapiens)
- Control of immune tolerance by vasoactive intestinal peptide - WP4484 (Homo sapiens)
- Relationship between inflammation, COX-2 and EGFR - WP4483 (Homo sapiens)
- Platelet-mediated interactions with vascular and circulating cells - WP4462 (Homo sapiens)
- Estrogen receptor pathway - WP2881 (Homo sapiens)
- Pathophysiological roles of DUX4 in FSHD1 - WP5342 (Homo sapiens)
- Th17 cell differentiation pathway - WP5130 (Homo sapiens)
- Network map of SARS-CoV-2 signaling - WP5115 (Homo sapiens)
- Proximal tubule transport - WP4917 (Homo sapiens)
- SARS coronavirus and innate immunity - WP4912 (Homo sapiens)
- 3q29 copy number variation syndrome - WP4906 (Homo sapiens)
- Purinergic signaling - WP4900 (Homo sapiens)
- CAMKK2 pathway - WP4874 (Homo sapiens)
- Mammalian disorder of sexual development - WP4842 (Homo sapiens)
- FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma - WP4553 (Homo sapiens)
- Inflammatory response pathway - WP453 (Homo sapiens)
- NPHP1 deletion syndrome - WP5399 (Homo sapiens)
- TAR syndrome - WP5362 (Homo sapiens)
- Kleefstra syndrome - WP5351 (Homo sapiens)
- Female steroid hormones in cardiomyocyte energy metabolism - WP5318 (Homo sapiens)
- 2q37 copy number variation syndrome - WP5224 (Homo sapiens)
- 2q13 copy number variation syndrome - WP5222 (Homo sapiens)
- DYRK1A involvement regarding cell proliferation in brain development - WP5180 (Homo sapiens)
- 15q13.3 copy number variation syndrome - WP4942 (Homo sapiens)
- 15q11.2 copy number variation syndrome - WP4940 (Homo sapiens)
- 7q11.23 copy number variation syndrome - WP4932 (Homo sapiens)
- Unfolded protein response - WP4925 (Homo sapiens)
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
- Peroxiredoxin 2 induced ovarian failure - WP4873 (Homo sapiens)
- Regucalcin in proximal tubule epithelial kidney cells - WP4838 (Homo sapiens)
- Purine metabolism - WP4792 (Homo sapiens)
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
- ADHD and autism (ASD) pathways - WP5420 (Homo sapiens)
- 8q11.23 (RB1CC1) copy number variation - WP5412 (Homo sapiens)
- 15q25 copy number variation - WP5408 (Homo sapiens)
- 15q11q13 copy number variation - WP5407 (Homo sapiens)
- 13q12.12 copy number variation - WP5406 (Homo sapiens)
- 10q22q23 copy number variation - WP5402 (Homo sapiens)
- 5q35 copy number variation - WP5380 (Homo sapiens)
- 17p13.3 (YWHAE) copy number variation - WP5376 (Homo sapiens)
- Osteoarthritic chondrocyte hypertrophy - WP5373 (Homo sapiens)
- 4p16.3 copy number variation - WP5365 (Homo sapiens)
- Affected pathways in Duchenne muscular dystrophy - WP5356 (Homo sapiens)
- Lactate shuttle in glial cells - WP5314 (Homo sapiens)
- 17q12 copy number variation syndrome - WP5287 (Homo sapiens)
- Glucocorticoid biosynthesis - WP5280 (Homo sapiens)
- Mineralocorticoid biosynthesis - WP5279 (Homo sapiens)
- Farnesyl to CoQ10 metabolism - WP5274 (Homo sapiens)
- LDL- influence on CD14 and TLR4 - WP5272 (Homo sapiens)
- Neurogenesis regulation in the olfactory epithelium - WP5265 (Homo sapiens)
- Cholestasis - WP5238 (Homo sapiens)
- Bardet-Biedl syndrome - WP5234 (Homo sapiens)
- Arsenic metabolism and reactive oxygen species generation - WP5233 (Homo sapiens)
- Hippocampal synaptogenesis and neurogenesis - WP5231 (Homo sapiens)
- Nephrotoxcicity adverse outcome pathway - WP5229 (Homo sapiens)
- Thyroid hormone imbalance leading to neurodevelopmental abnormalities - WP5227 (Homo sapiens)
- 2q21.1 copy number variation syndrome - WP5223 (Homo sapiens)
- 2q11.2 copy number variation syndrome - WP5221 (Homo sapiens)
- Metabolic reprogramming in pancreatic cancer - WP5220 (Homo sapiens)
- Amino acid metabolism in triple-negative breast cancer cells - WP5213 (Homo sapiens)
- Glucose metabolism in triple-negative breast cancer cells - WP5211 (Homo sapiens)
- Dravet syndrome - WP5200 (Homo sapiens)
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids - WP5192 (Homo sapiens)
- SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction - WP5183 (Homo sapiens)
- Roles of ceramides in development of insulin resistance - WP5181 (Homo sapiens)
- Disorders of fructose metabolism - WP5178 (Homo sapiens)
- Spina bifida - WP5150 (Homo sapiens)
- ALA oxylipin metabolism - WP5136 (Homo sapiens)
- Mitochondrial fatty acid oxidation disorders - WP5123 (Homo sapiens)
- SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation - WP5116 (Homo sapiens)
- Nucleotide excision repair in xeroderma pigmentosum - WP5114 (Homo sapiens)
- Familial hyperlipidemia type 5 - WP5112 (Homo sapiens)
- Familial hyperlipidemia type 4 - WP5111 (Homo sapiens)
- Familial hyperlipidemia type 2 - WP5109 (Homo sapiens)
- Familial hyperlipidemia type 1 - WP5108 (Homo sapiens)
- Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia - WP5105 (Homo sapiens)
- Vasopressin-regulated water reabsorption - WP5085 (Homo sapiens)
- Modulators of TCR signaling and T cell activation - WP5072 (Homo sapiens)
- Fatty acid transporters - WP5061 (Homo sapiens)
- Development of ureteric collection system - WP5053 (Homo sapiens)
- Nephrogenesis - WP5052 (Homo sapiens)
- ACE2 inhibition leads to pulmonary fibrosis - WP5035 (Homo sapiens)
- Genes associated with the development of rheumatoid arthritis - WP5033 (Homo sapiens)
- Phosphoinositides metabolism - WP4971 (Homo sapiens)
- Galanin receptor pathway - WP4970 (Homo sapiens)
- p53 transcriptional gene network - WP4963 (Homo sapiens)
- Complement system - WP2806 (Homo sapiens)
- TCA cycle - WP999 (Bos taurus)
- Mitochondrial long chain fatty acid beta-oxidation - WP989 (Bos taurus)
- EBV LMP1 signaling - WP984 (Bos taurus)
- Amino acid conjugation - WP715 (Homo sapiens)
- Aflatoxin B1 metabolism - WP699 (Homo sapiens)
- Glucuronidation - WP698 (Homo sapiens)
- Estrogen metabolism - WP697 (Homo sapiens)
- Arylamine metabolism - WP694 (Homo sapiens)
- Tamoxifen metabolism - WP691 (Homo sapiens)
- Arachidonate epoxygenase / epoxide hydrolase - WP678 (Homo sapiens)
- Oxidative phosphorylation - WP623 (Homo sapiens)
- Type II interferon signaling - WP619 (Homo sapiens)
- Interferon type I signaling - WP585 (Homo sapiens)
- Dauer formation - WP580 (Caenorhabditis elegans)
- Exercise-induced circadian regulation - WP562 (Danio rerio)
- Complement and coagulation cascades - WP558 (Homo sapiens)
- Wnt/Beta-catenin signaling inhibitors in current and past clinical trials - WP5442 (Homo sapiens)
- HDAC6 interactions in the central nervous system - WP5426 (Homo sapiens)
- Omega-6-fatty acids in senescence - WP5424 (Homo sapiens)
- Phosphatidyl inositol phosphate pathway - WP5411 (Homo sapiens)
- PAFAH1B1 copy number variation - WP5409 (Homo sapiens)
- 13q12 or CRYL1 copy number variation - WP5405 (Homo sapiens)
- 7q11.23 distal copy number variation - WP5401 (Homo sapiens)
- 6q16 copy number variation - WP5400 (Homo sapiens)
- NRXN1 deletion syndrome - WP5398 (Homo sapiens)
- Vitamin A1 and A5/X pathways - WP5397 (Homo sapiens)
- Glycosaminoglycan synthesis in fibroblasts - WP5395 (Homo sapiens)
- UDP-derived sugars synthesis in fibroblasts - WP5394 (Homo sapiens)
- Pancreatic cancer subtypes - WP5390 (Homo sapiens)
- DNA adduct formation leading to kidney failure - WP5389 (Homo sapiens)
- Smith-Magenis and Potocki-Lupski syndrome copy number variation - WP5381 (Homo sapiens)
- Sulfatase and aromatase pathway - WP5368 (Homo sapiens)
- NF1 copy number variation syndrome - WP5366 (Homo sapiens)
- 11p11.2 copy number variation syndrome - WP5348 (Homo sapiens)
- 8p23.1 copy number variation syndrome - WP5346 (Homo sapiens)
- 1p36 copy number variation syndrome - WP5345 (Homo sapiens)
- Autophagy in pancreatic ductal adenocarcinoma - WP5331 (Homo sapiens)
- Cholesterol biosynthesis pathway in hepatocytes - WP5329 (Homo sapiens)
- Octadecanoid formation from linoleic acid - WP5324 (Homo sapiens)
- Prostaglandin and leukotriene metabolism in senescence - WP5321 (Homo sapiens)
- Male steroid hormones in cardiomyocyte energy metabolism - WP5320 (Homo sapiens)
- Sebaleic acid formation and metabolism - WP5315 (Homo sapiens)
- Isoglobo series sphingolipids - WP5311 (Homo sapiens)
- Lacto series sphingolipid metabolism - WP5303 (Homo sapiens)
- Neolacto series sphingolipid metabolism - WP5302 (Homo sapiens)
- Ganglio series sphingolipid metabolism - WP5299 (Homo sapiens)
- Sildenafil treatment - WP5294 (Homo sapiens)
- Glycosphingolipid metabolism - WP5292 (Homo sapiens)
- Disorders of galactose metabolism - WP5173 (Homo sapiens)
- Complement system in neuronal development and plasticity - WP5090 (Homo sapiens)
- T cell modulation in pancreatic cancer - WP5078 (Homo sapiens)
- Burn wound healing - WP5057 (Rattus norvegicus)
- Burn wound healing - WP5056 (Mus musculus)
- Burn wound healing - WP5055 (Homo sapiens)
- Kynurenine pathway and links to cell senescence - WP5044 (Homo sapiens)
- Pentose phosphate pathway in senescent cells - WP5043 (Homo sapiens)
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
- Glutamate degradation III - WP503 (Saccharomyces cerevisiae)
- Airway smooth muscle cell contraction - WP4962 (Homo sapiens)
- MAPK pathway in congenital thyroid cancer - WP4928 (Homo sapiens)
- TCA cycle - WP490 (Saccharomyces cerevisiae)
- Overlap between signal transduction pathways contributing to LMNA laminopathies - WP4879 (Homo sapiens)
- Hijack of ubiquitination by SARS-CoV-2 - WP4860 (Homo sapiens)
- Influence of laminopathies on Wnt signaling - WP4844 (Homo sapiens)
- Joubert syndrome - WP4656 (Homo sapiens)
- Aerobic glycolysis - WP4629 (Homo sapiens)
- Mitochondrial gene expression - WP391 (Homo sapiens)
- Triacylglyceride synthesis - WP386 (Mus musculus)
- ESC pluripotency pathways - WP339 (Mus musculus)
- Ebstein-Barr virus LMP1 signaling - WP262 (Homo sapiens)
- Principal pathways of carbon metabolism - WP112 (Saccharomyces cerevisiae)
- Post-COVID neuroinflammation - WP5485 (Homo sapiens)
- Catabolism of skeletal muscle in cachexia - WP5474 (Homo sapiens)
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
- Mitochondrial immune response to SARS-CoV-2 - WP5038 (Homo sapiens)
- Aspirin and miRNAs - WP4707 (Homo sapiens)
- Aerobic glycolysis - augmented - WP4628 (Homo sapiens)
- Fragile X syndrome - WP4549 (Homo sapiens)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523 (Homo sapiens)
- Biotic stress response gene network - WP4364 (Oryza sativa)
- Rett syndrome - WP4312 (Homo sapiens)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Flavan-3-ol metabolic pathway - WP4238 (Homo sapiens)
- Purine metabolism and related disorders - WP4224 (Homo sapiens)
- Ebola virus infection in host - WP4217 (Homo sapiens)
- Chromosomal and microsatellite instability in colorectal cancer - WP4216 (Homo sapiens)
- Embryonic stem cell pluripotency pathways - WP3931 (Homo sapiens)
- Angiopoietin-like protein 8 regulatory pathway - WP3915 (Homo sapiens)
- Dengue-2 interactions with complement and coagulation cascades - WP3896 (Homo sapiens)
- Nanomaterial-induced inflammasome activation - WP3890 (Homo sapiens)
- AtMetExpress overview - WP3622 (Arabidopsis thaliana)
- Zinc homeostasis - WP3529 (Homo sapiens)
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
- Folate metabolism - WP1075 (Bos taurus)
- Effect of omega-3 PUFA on Huntington's disease pathways - WP5470 (Homo sapiens)
- Pathways affected in adenoid cystic carcinoma - WP3651 (Homo sapiens)
- Endothelin pathways - WP3246 (Bos taurus)
- Differentiation pathway - WP3223 (Bos taurus)
- Quercetin and Nf-kB / AP-1 induced cell apoptosis - WP3167 (Bos taurus)
- Mitochondrial gene expression - WP3134 (Bos taurus)
- Monoamine transport - WP3118 (Bos taurus)
- Hair follicle development: cytodifferentiation - stage 3 of 3 - WP2840 (Homo sapiens)
- Mammary gland development: pregnancy and lactation - stage 3 of 4 - WP2817 (Homo sapiens)
- Quercetin and Nf-kB / AP-1 induced apoptosis - WP2435 (Homo sapiens)
- DNA damage response (only ATM dependent) - WP710 (Homo sapiens)
- TROP2 regulatory signaling - WP5300 (Homo sapiens)
- ROS in COVID-19 endothelial dysfunction - WP5258 (Homo sapiens)
- Immune response to tuberculosis - WP4197 (Homo sapiens)
- ApoE and miR-146 in inflammation and atherosclerosis - WP3926 (Homo sapiens)
- ApoE and miR-146 in inflammation and atherosclerosis - WP3592 (Mus musculus)
- Seed development - WP2279 (Arabidopsis thaliana)
- Androgen receptor network in prostate cancer - WP2263 (Homo sapiens)
- Seed development - WP2199 (Oryza sativa)
- Oxylipins pathways - WP5140 (Mus musculus)
- Familial hyperlipidemia type 3 - WP5110 (Homo sapiens)
- Endothelin pathways - WP2197 (Homo sapiens)
- RANKL/RANK signaling - WP2018 (Homo sapiens)
- Nucleotide-binding oligomerization domain (NOD) pathway - WP1433 (Homo sapiens)
- Folic acid network - WP1311 (Rattus norvegicus)
- Nod-like receptor (NLR) signaling pathway - WP1294 (Rattus norvegicus)
- Folic acid network - WP1273 (Mus musculus)
- Mitochondrial gene expression - WP1263 (Mus musculus)
- Nod-like receptor (NLR) signaling pathway - WP1256 (Mus musculus)
- Arachidonate epoxygenase / epoxide hydrolase - WP1250 (Mus musculus)
- Heme biosynthesis - WP1221 (Anopheles gambiae)
- Heme biosynthesis - WP1086 (Canis familiaris)
- Complement and coagulation cascades - WP1056 (Bos taurus)
- IL-4 signaling pathway - WP1055 (Bos taurus)
- Nod-like receptor (NLR) signaling pathway - WP1032 (Bos taurus)
- Arachidonate epoxygenase / epoxide hydrolase - WP1000 (Bos taurus)
- Monoamine transport - WP727 (Homo sapiens)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- MAPK cascade - WP422 (Homo sapiens)
- TYROBP causal network in microglia - WP3945 (Homo sapiens)
- FTO obesity variant mechanism - WP3407 (Homo sapiens)
- RAC1/PAK1/p38/MMP2 pathway - WP3303 (Homo sapiens)
- Type 2 papillary renal cell carcinoma - WP4241 (Homo sapiens)
- Statin pathway - WP1 (Mus musculus)
- Sulfur amino acid biosynthesis - WP7 (Saccharomyces cerevisiae)
- Folate metabolism - WP176 (Homo sapiens)
- AMP-activated protein kinase signaling - WP1403 (Homo sapiens)
- Sucrose biosynthesis - WP14 (Saccharomyces cerevisiae)
- Electron transport chain: OXPHOS system in mitochondria - WP111 (Homo sapiens)
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091 (Homo sapiens)
- Microtubule cytoskeleton regulation - WP2038 (Homo sapiens)
- Polycystic kidney disease pathway - WP2571 (Homo sapiens)
- Cytokine-cytokine receptor interaction - WP5473 (Homo sapiens)
- Axon guidance - WP5289 (Homo sapiens)
- Inflammatory bowel disease signaling - WP5198 (Homo sapiens)
- miRNA regulation of prostate cancer signaling - WP3981 (Homo sapiens)
- Chemokine signaling - WP3929 (Homo sapiens)
- Focal adhesion - WP306 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Vitamin B12 metabolism - WP1533 (Homo sapiens)
- Lysine biosynthesis - WP533 (Saccharomyces cerevisiae)
- Phosphoinositide 3-kinase (PI3K) family - WP5472 (Homo sapiens)
- Receptor tyrosine kinase (RTK) family - WP5471 (Homo sapiens)
- Artemisinin inhibition of uveal melanoma - WP5441 (Homo sapiens)
- Hippo signaling regulation - WP4540 (Homo sapiens)
- Extracellular vesicle-mediated signaling in recipient cells - WP2870 (Homo sapiens)
- Common pathways underlying drug addiction - WP2636 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- Toll-like receptor signaling - WP75 (Homo sapiens)
- Estrogen signaling - WP712 (Homo sapiens)
- T-cell receptor signaling - WP69 (Homo sapiens)
- ErbB signaling - WP673 (Homo sapiens)
- Notch signaling - WP61 (Homo sapiens)
- FLT3 p.Gln640SerfsTer8 signaling - WP5431 (Homo sapiens)
- IL19 signaling - WP5422 (Homo sapiens)
- TGFB / Smad signaling - WP5382 (Homo sapiens)
- IL26 signaling - WP5347 (Homo sapiens)
- Cardiomyocyte signaling converging on titin - WP5344 (Homo sapiens)
- Induction of autophagy and toll-like receptor signaling by graphene oxide - WP5336 (Homo sapiens)
- ID signaling - WP53 (Homo sapiens)
- G13 signaling - WP524 (Homo sapiens)
- Urotensin-II-mediated signaling - WP5158 (Homo sapiens)
- NRP1-triggered signaling in pancreatic cancer - WP5144 (Homo sapiens)
- CCL18 signaling - WP5097 (Homo sapiens)
- IL2 signaling - WP49 (Homo sapiens)
- MAP3K1 role in promoting and blocking gonadal determination - WP4872 (Homo sapiens)
- PKC-gamma calcium signaling in ataxia - WP4760 (Homo sapiens)
- IL18 signaling - WP4754 (Homo sapiens)
- Netrin-UNC5B signaling - WP4747 (Homo sapiens)
- Hedgehog signaling - WP47 (Homo sapiens)
- Gastrin signaling - WP4659 (Homo sapiens)
- Interferon-mediated signaling - WP4558 (Homo sapiens)
- Regulatory circuits of STAT3 signaling - WP4538 (Homo sapiens)
- IL10 anti-inflammatory signaling - WP4495 (Homo sapiens)
- EGF/EGFR signaling - WP437 (Homo sapiens)
- Hedgehog signaling - WP4249 (Homo sapiens)
- PI3K-Akt signaling - WP4172 (Homo sapiens)
- Fibrin complement receptor 3 signaling - WP4136 (Homo sapiens)
- Wnt signaling - WP403 (Mus musculus)
- p38 MAPK signaling - WP400 (Homo sapiens)
- Wnt signaling and pluripotency - WP399 (Homo sapiens)
- IL4 signaling - WP395 (Homo sapiens)
- ROBO4 and VEGF signaling crosstalk - WP3943 (Homo sapiens)
- PPAR signaling - WP3942 (Homo sapiens)
- Focal adhesion: PI3K-Akt-mTOR-signaling - WP3932 (Homo sapiens)
- MAPK and NFkB signaling inhibited by Yersinia YopJ - WP3849 (Homo sapiens)
- MAPK signaling - WP382 (Homo sapiens)
- Wnt/beta-catenin signaling in leukemia - WP3658 (Homo sapiens)
- Equilibrium signaling of differentiated cells - WP3653 (Drosophila melanogaster)
- IL6 signaling - WP364 (Homo sapiens)
- Wnt signaling - WP363 (Homo sapiens)
- G protein signaling - WP35 (Homo sapiens)
- Kit receptor signaling - WP304 (Homo sapiens)
- Nod-like receptor (NLR) signaling - WP288 (Homo sapiens)
- IL3 signaling - WP286 (Homo sapiens)
- ATM signaling - WP2516 (Homo sapiens)
- Alpha 6 beta 4 signaling - WP244 (Homo sapiens)
- Brain-derived neurotrophic factor (BDNF) signaling - WP2380 (Homo sapiens)
- Oncostatin M signaling - WP2374 (Homo sapiens)
- Corticotropin-releasing hormone signaling - WP2355 (Homo sapiens)
- IL11 signaling - WP2332 (Homo sapiens)
- TNF-alpha signaling - WP231 (Homo sapiens)
- B cell receptor signaling - WP23 (Homo sapiens)
- Glioblastoma signaling - WP2261 (Homo sapiens)
- Thymic stromal lymphopoietin (TSLP) signaling - WP2203 (Homo sapiens)
- IL9 signaling - WP22 (Homo sapiens)
- IL17 signaling - WP2112 (Homo sapiens)
- IL7 signaling - WP205 (Homo sapiens)
- Prolactin signaling - WP2037 (Homo sapiens)
- TNF-related weak inducer of apoptosis (TWEAK) signaling - WP2036 (Homo sapiens)
- Follicle stimulating hormone (FSH) signaling - WP2035 (Homo sapiens)
- Leptin signaling - WP2034 (Homo sapiens)
- Thyroid stimulating hormone (TSH) signaling - WP2032 (Homo sapiens)
- IL1 signaling - WP195 (Homo sapiens)
- Androgen receptor signaling - WP138 (Homo sapiens)
- IL5 signaling - WP127 (Homo sapiens)
- Resolvin E1 and resolvin D1 signaling decrease inflammation - WP5191 (Homo sapiens)
- Senescence-associated secretory phenotype (SASP) - WP3391 (Homo sapiens)
- Triacylglyceride synthesis - WP325 (Homo sapiens)
- Hepatitis B infection - WP4666 (Homo sapiens)
- H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer - WP3969 (Homo sapiens)
- Development and heterogeneity of the ILC family - WP3893 (Homo sapiens)
- PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer - WP3844 (Homo sapiens)
- Malate-aspartate shuttle - WP4315 (Homo sapiens)
- Involvement of δ-secretase in neurodegenerative diseases - WP5372 (Homo sapiens)
- Enterocyte cholesterol metabolism - WP5333 (Homo sapiens)
- Cholesterol metabolism - WP5304 (Homo sapiens)
- Synaptic signaling associated with autism spectrum disorder - WP4539 (Homo sapiens)
- Bile acid synthesis and enterohepatic circulation - WP4389 (Homo sapiens)
- Heart development - WP1591 (Homo sapiens)
- Statin pathway - WP1041 (Bos taurus)
- Macrophage-stimulating protein (MSP) signaling - WP5353 (Homo sapiens)
- Selenium metabolism and selenoproteins - WP28 (Homo sapiens)
- One-carbon metabolism - WP1292 (Rattus norvegicus)
- Prion disease pathway - WP3995 (Homo sapiens)
- Metabolism of T-2 toxin and HT-2 toxin - WP5425 (Triticum aestivum)
- Metabolic epileptic disorders - WP5355 (Homo sapiens)
- Effects of MFN2 mutation - WP5443 (Homo sapiens)
- Cancer pathways - WP5434 (Homo sapiens)
- Intracellular trafficking proteins involved in CMT neuropathy - WP4856 (Homo sapiens)
- Ovarian infertility - WP34 (Homo sapiens)
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936 (Homo sapiens)
- DNA replication - WP983 (Bos taurus)
- GNAQ pathways in port-wine stain - WP5437 (Homo sapiens)
- Fatty acids and lipoproteins transport in hepatocytes - WP5323 (Homo sapiens)
- Arsenic liver toxicity pathway - WP5228 (Homo sapiens)
- Ulcerative colitis signaling - WP5174 (Homo sapiens)
- SARS-CoV-2 replication organelle formation - WP5156 (Homo sapiens)
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941 (Homo sapiens)
- Type I collagen synthesis in the context of osteogenesis imperfecta - WP4786 (Homo sapiens)
- Melanoma - WP4685 (Homo sapiens)
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
- Oligodendrocyte specification and differentiation, leading to myelin components for CNS - WP4304 (Homo sapiens)
- MET in type 1 papillary renal cell carcinoma - WP4205 (Homo sapiens)
- Biosynthesis of the three types of mycolic acids - WP4198 (Mycobacterium tuberculosis)
- Liver steatosis adverse outcome pathway - WP4010 (Homo sapiens)
- Development of pulmonary dendritic cells and macrophage subsets - WP3892 (Homo sapiens)
- Estrogen receptor pathway - WP3163 (Bos taurus)
- Left-right asymmetry in the nervous system - WP2229 (Caenorhabditis elegans)
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
- Rubinstein-Taybi syndrome 1 - WP5367 (Homo sapiens)
- NIPBL role in DNA damage - Cornelia de Lange syndrome - WP5119 (Homo sapiens)
- SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome - WP5118 (Homo sapiens)
- Cohesin complex - Cornelia de Lange syndrome - WP5117 (Homo sapiens)
- STING pathway in Kawasaki-like disease and COVID-19 - WP4961 (Homo sapiens)
- Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome - WP4944 (Homo sapiens)
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485 (Homo sapiens)
- Degradation pathway of sphingolipids, including diseases - WP4153 (Homo sapiens)
- Wnt signaling in kidney disease - WP4150 (Homo sapiens)
- Wnt signaling in kidney disease - WP3857 (Mus musculus)
- MicroRNA for targeting cancer growth and vascularization in glioblastoma - WP3593 (Homo sapiens)
- Mecp2 and associated Rett syndrome - WP2910 (Mus musculus)
- Hypothetical craniofacial development pathway - WP3655 (Homo sapiens)
- Ectodysplasin A signaling in hair follicle development - WP3652 (Mus musculus)
- Wnt myofibroblastic activation of hepatic stellate cells - WP3649 (Rattus norvegicus)
- GLP-1 secretion from intestine to portal vein - WP5446 (Homo sapiens)
- Cytokines and inflammatory response - WP530 (Homo sapiens)
- Extrafollicular and follicular B cell activation by SARS-CoV-2 - WP5218 (Homo sapiens)
- Heme biosynthesis - WP102 (Saccharomyces cerevisiae)
- GLP-1 from intestine and pancreas and role in glucose homeostasis - WP5452 (Homo sapiens)
- GLP-1 in pancreatic islet cells - WP5447 (Homo sapiens)
- Hunger and satiety - WP5445 (Homo sapiens)
- Cell interactions of the pancreatic cancer microenvironment - WP5284 (Homo sapiens)
- Markers of kidney cell lineage - WP5236 (Homo sapiens)
- mRNA vaccine activation of dendritic cell and induction of IFN-1 - WP5187 (Homo sapiens)
- T-cell activation SARS-CoV-2 - WP5098 (Homo sapiens)
- Measles virus infection - WP4630 (Homo sapiens)
- Selective expression of chemokine receptors during T-cell polarization - WP4494 (Homo sapiens)
- Altered glycosylation of MUC1 in tumor microenvironment - WP4480 (Homo sapiens)
- Suppression of HMGB1-mediated inflammation by THBD - WP4479 (Homo sapiens)
- LTF danger signal response pathway - WP4478 (Homo sapiens)
- Ethanol metabolism production of ROS by CYP2E1 - WP4269 (Homo sapiens)
- Poly(glycerol phosphate) wall teichoic acid biosynthesis - WP4162 (Saccharomyces cerevisiae)
- Intracellular auxin transport - WP3628 (Arabidopsis thaliana)
- Hematopoietic stem cell differentiation - WP2849 (Homo sapiens)
- Glial cell differentiation - WP2276 (Homo sapiens)
- Dopaminergic neurogenesis - WP1498 (Mus musculus)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- Mitochondrial complex inhibition leading to liver injury - WP5034 (Homo sapiens)
- Secretion of hydrochloric acid in parietal cells - WP2597 (Homo sapiens)
- Gastric acid production - WP2596 (Homo sapiens)
- Kinin-Kallikrein pathway - WP5089 (Homo sapiens)
- Serotonin and anxiety - WP3947 (Homo sapiens)
- Serotonin and anxiety-related events - WP3944 (Homo sapiens)
- ERK pathway in Huntington's disease - WP3853 (Homo sapiens)
- Acetaminophen in analgesia and antipyresis - WP5444 (Homo sapiens)
- Downregulation of ACE2 by SARS-CoV-2 spike protein - WP4799 (Homo sapiens)
- Physiological and pathological hypertrophy of the heart - WP1528 (Homo sapiens)
- TCA cycle (aka Krebs or citric acid cycle) - WP78 (Homo sapiens)
- Oxidative stress response - WP408 (Homo sapiens)
- Wnt signaling pathway - WP1349 (Danio rerio)
- ATM signaling in development and disease - WP3878 (Homo sapiens)
- Steroid biosynthesis - WP496 (Homo sapiens)
- Hypothesized pathways in pathogenesis of cardiovascular disease - WP3668 (Homo sapiens)
- Ciliopathies - WP4803 (Homo sapiens)
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
- TGF-beta receptor signaling in skeletal dysplasias - WP4816 (Homo sapiens)
- Endochondral ossification with skeletal dysplasias - WP4808 (Homo sapiens)
- FGF23 signaling in hypophosphatemic rickets and related disorders - WP4790 (Homo sapiens)
- Multiple epiphyseal dysplasia and pseudoachondroplasia genes - WP4789 (Homo sapiens)
- Autosomal recessive osteopetrosis pathways - WP4788 (Homo sapiens)
- Somitogenesis in the context of spondylocostal dysostosis - WP4785 (Homo sapiens)
- Proteoglycan biosynthesis - WP4784 (Homo sapiens)
- Endochondral ossification - WP474 (Homo sapiens)
- Alstrom syndrome - WP5202 (Homo sapiens)
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535 (Homo sapiens)
- Effect of progerin on genes involved in progeria - WP4320 (Homo sapiens)
- Lamin A processing pathway - WP4299 (Homo sapiens)
- DNA damage response - WP707 (Homo sapiens)
- p53 pathway - WP655 (Rattus norvegicus)
- 10q11.21q11.23 copy number variation syndrome - WP5352 (Homo sapiens)
- Hypoxia-dependent differentiation of myoblasts - WP5025 (Mus musculus)
- Hypoxia-dependent self-renewal of myoblasts - WP5023 (Mus musculus)
- Kisspeptin/kisspeptin receptor system in the ovary - WP4871 (Homo sapiens)
- Thyroid hormones production and peripheral downstream signaling effects - WP4746 (Homo sapiens)
- Pathways of nucleic acid metabolism and innate immune sensing - WP4705 (Homo sapiens)
- 22q11.2 copy number variation syndrome - WP4657 (Homo sapiens)
- FABP4 in ovarian cancer - WP4400 (Homo sapiens)
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397 (Homo sapiens)
- Neovascularization processes - WP4331 (Homo sapiens)
- miRNA role in immune response in sepsis - WP4329 (Homo sapiens)
- Epithelial to mesenchymal transition in colorectal cancer - WP4239 (Homo sapiens)
- miRNA regulation of p53 pathway in prostate cancer - WP3982 (Homo sapiens)
- Dysregulated miRNA targeting in insulin/PI3K-AKT signaling - WP3855 (Mus musculus)
- Cell-type dependent selectivity of CCK2R signaling - WP3679 (Homo sapiens)
- Photodynamic therapy-induced NF-kB survival signaling - WP3617 (Homo sapiens)
- Angiogenesis - WP3184 (Bos taurus)
- SIDS susceptibility pathways - WP3130 (Bos taurus)
- Hypoxia-mediated EMT and stemness - WP2943 (Homo sapiens)
- Focal adhesion: PI3K-Akt-mTOR signaling pathway - WP2841 (Mus musculus)
- Effects of nitric oxide - WP1995 (Homo sapiens)
- N-glycan biosynthesis - WP5196 (Ovis aries)
- Overview of proinflammatory and profibrotic mediators - WP5095 (Homo sapiens)
- DNA replication - WP466 (Homo sapiens)
- Flowering time pathway - WP4339 (Brassica napus)
- Oxytocin signaling - WP2889 (Homo sapiens)
- Flowering time pathway - WP2625 (Hordeum vulgare)
- One-carbon metabolism - WP241 (Homo sapiens)
- Thyroxine (thyroid hormone) production - WP1981 (Homo sapiens)
- TCA cycle - WP19 (Danio rerio)
- GABA receptor signaling - WP4159 (Homo sapiens)
- Mammary gland development pathway - Involution (Stage 4 of 4) - WP2815 (Homo sapiens)
- Mammary gland development pathway - Puberty (Stage 2 of 4) - WP2814 (Homo sapiens)
- Mammary gland development pathway - Embryonic development (Stage 1 of 4) - WP2813 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880 (Homo sapiens)
- Drug induction of bile acid pathway - WP2289 (Homo sapiens)
- Breast cancer pathway - WP4262 (Homo sapiens)
- Drug induction of bile acid pathway - WP3253 (Bos taurus)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- Irinotecan pathway - WP229 (Homo sapiens)
- Irinotecan pathway - WP1080 (Bos taurus)
- Angiotensin II receptor type 1 pathway - WP5036 (Homo sapiens)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition - WP4914 (Homo sapiens)
- 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression - WP3879 (Homo sapiens)
- ATR signaling - WP3875 (Homo sapiens)
- Regulation of apoptosis by parathyroid hormone-related protein - WP3872 (Homo sapiens)
- Striated muscle contraction pathway - WP383 (Homo sapiens)
- Amplification and expansion of oncogenic pathways as metastatic traits - WP3678 (Homo sapiens)
- Vitamin D metabolism - WP1531 (Homo sapiens)
- Endometrial cancer - WP4155 (Homo sapiens)
- ACE inhibitor pathway - WP554 (Homo sapiens)
- 7-oxo-C and 7-beta-HC pathways - WP5064 (Homo sapiens)
- Amino acid transport defects (IEMs) - WP5029 (Homo sapiens)
- Alternative pathway of fetal androgen synthesis - WP4524 (Homo sapiens)
- Angiogenesis - WP1539 (Homo sapiens)
- Enterohepatic circulation of bile acids - WP5396 (Homo sapiens)
- Steroid hormone precursor biosynthesis - WP5277 (Homo sapiens)
- Cholesterol biosynthesis with skeletal dysplasias - WP4804 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- Disorders of folate metabolism and transport - WP4259 (Homo sapiens)
- NAD metabolism, sirtuins and aging - WP3630 (Homo sapiens)
- Bladder cancer - WP2828 (Homo sapiens)
- Riboflavin and CoQ disorders - WP5037 (Homo sapiens)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- Metabolism of sphingolipids in ER and Golgi apparatus - WP4142 (Homo sapiens)
- Cell lineage map for neuronal differentiation - WP5417 (Homo sapiens)
- Growth factors and hormones in beta cell proliferation - WP5385 (Homo sapiens)
- JAK-STAT signaling in the regulation of beta cells - WP5358 (Homo sapiens)
- Genetic causes of porto-sinusoidal vascular disease - WP5269 (Homo sapiens)
- Alzheimer's disease - WP5124 (Homo sapiens)
- Acquired partial lipodystrophy / Barraquer-Simons syndrome - WP5104 (Homo sapiens)
- Burn wound healing - WP5058 (Sus scrofa)
- 16p11.2 distal deletion syndrome - WP4950 (Homo sapiens)
- Cellular proteostasis - WP4918 (Homo sapiens)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Lipid metabolism pathway - WP3965 (Homo sapiens)
- Gene regulatory network modeling somitogenesis - WP2854 (Homo sapiens)
- Histone modifications - WP2369 (Homo sapiens)
- Biotin metabolism - WP1631 (Mycobacterium tuberculosis)
- Type II diabetes mellitus - WP1584 (Homo sapiens)
- EPAC1 and PKA reduction of retinal inflammation - WP5440 (Homo sapiens)
- Sphingolipid metabolism overview - WP4725 (Homo sapiens)
- Chronic hyperglycemia impairment of neuron function - WP5283 (Homo sapiens)
- Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway) - WP5148 (Homo sapiens)
- Lung pathology of COVID-19 - WP5146 (Homo sapiens)
- COVID-19 structural coverage map - WP5145 (Homo sapiens)
- OSX and miRNAs in tooth development - WP3971 (Homo sapiens)
- miRNA targets in ECM and membrane receptors - WP2911 (Homo sapiens)
- Parkinson's disease pathway - WP2371 (Homo sapiens)
- Immune infiltration in pancreatic cancer - WP5285 (Homo sapiens)
- Ether lipid biosynthesis - WP5275 (Homo sapiens)
- Disorders in ketolysis - WP5195 (Homo sapiens)
- Creatine pathway - WP5190 (Homo sapiens)
- Copper metabolism - WP5189 (Homo sapiens)
- Disorders of bile acid synthesis and biliary transport - WP5176 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Iron metabolism disorders - WP5172 (Homo sapiens)
- Hemesynthesis defects and porphyrias - WP5169 (Homo sapiens)
- Glyoxylate metabolism - WP5166 (Homo sapiens)
- Ethylmalonic encephalopathy - WP5030 (Homo sapiens)
- FGFR3 signaling in chondrocyte proliferation and terminal differentiation - WP4767 (Homo sapiens)
- Leucine, isoleucine and valine metabolism - WP4686 (Homo sapiens)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- Hippo-Merlin signaling dysregulation - WP4541 (Homo sapiens)
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
- Molybdenum cofactor (Moco) biosynthesis - WP4507 (Homo sapiens)
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292 (Homo sapiens)
- MTHFR deficiency - WP4288 (Homo sapiens)
- Vitamin B12 disorders - WP4271 (Homo sapiens)
- Krebs cycle disorders - WP4236 (Homo sapiens)
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
- GABA metabolism (aka GHB) - WP4157 (Homo sapiens)
- Hepatitis C and hepatocellular carcinoma - WP3646 (Homo sapiens)
- MECP2 and associated Rett syndrome - WP3584 (Homo sapiens)
- Complement activation - WP545 (Homo sapiens)
- Cholesterol synthesis disorders - WP5193 (Homo sapiens)
- Calcium mediated T-cell apoptosis involved in inclusion body myositis - WP5142 (Homo sapiens)
- Proline and hydroxyproline pathways - WP5026 (Homo sapiens)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Tyrosine metabolism and related disorders - WP4506 (Homo sapiens)
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156 (Homo sapiens)
- Copper homeostasis - WP3286 (Homo sapiens)
- Apoptosis - WP254 (Homo sapiens)
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
- Phase I biotransformations, non-P450 - WP136 (Homo sapiens)
- Phase I biotransformations, non-P450 - WP1291 (Rattus norvegicus)
- Phase I biotransformations, non-P450 - WP1213 (Equus caballus)
- Phase I biotransformations, non-P450 - WP1021 (Bos taurus)
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
- BDNF-TrkB signaling - WP3676 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
- Cholesterol biosynthesis pathway - WP197 (Homo sapiens)
- Apoptosis modulation and signaling - WP1772 (Homo sapiens)
- KCNQ2-related epilepsies - WP5360 (Homo sapiens)
- Glycolysis and gluconeogenesis - WP534 (Homo sapiens)
- Acetylcholine synthesis - WP528 (Homo sapiens)
- Activation of NLRP3 inflammasome by SARS-CoV-2 - WP4876 (Homo sapiens)
- Canonical and non-canonical TGF-B signaling - WP3874 (Homo sapiens)
- PCSK9-mediated LDL receptor degradation - WP2846 (Homo sapiens)
- Synaptic vesicle pathway - WP2267 (Homo sapiens)
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
- Focal adhesion - WP85 (Mus musculus)
- Nucleotide GPCRs - WP80 (Homo sapiens)
- Tryptophan metabolism - WP79 (Mus musculus)
- Insulin signaling - WP65 (Mus musculus)
- Monoamine GPCRs - WP58 (Homo sapiens)
- Steroid biosynthesis - WP55 (Mus musculus)
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235 (Homo sapiens)
- Regulation of actin cytoskeleton - WP51 (Homo sapiens)
- Prostaglandin signaling - WP5088 (Homo sapiens)
- G1 to S cell cycle control - WP45 (Homo sapiens)
- GPCRs, class C metabotropic glutamate, pheromone - WP42 (Rattus norvegicus)
- GPCRs, other - WP41 (Mus musculus)
- Inflammatory response pathway - WP40 (Rattus norvegicus)
- IDO metabolic pathway - WP5414 (Homo sapiens)
- Fatty acid omega-oxidation - WP33 (Mus musculus)
- Translation factors - WP32 (Saccharomyces cerevisiae)
- Notch signaling pathway - WP29 (Mus musculus)
- Fatty acid beta-oxidation 3 - WP25 (Drosophila melanogaster)
- Peptide GPCRs - WP24 (Homo sapiens)
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
- Glycine metabolism, including IMDs - WP5028 (Homo sapiens)
- MYD88 distinct input-output pathway - WP3877 (Homo sapiens)
- Canonical and non-canonical Notch signaling - WP3845 (Homo sapiens)
- SREBF and miR33 in cholesterol and lipid homeostasis - WP2011 (Homo sapiens)
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
- PGK1, PKM2, KHKC/KHKA acting as protein kinases - WP5433 (Homo sapiens)
- EV release from cardiac cells and their functional effects - WP3297 (Homo sapiens)
- High-osmolarity glycerol (HOG) pathway - WP2838 (Saccharomyces cerevisiae)
- Renin-angiotensin-aldosterone system (RAAS) - WP4756 (Homo sapiens)
- Interleukin-1 (IL-1) structural pathway - WP2637 (Homo sapiens)
- Methionine de novo and salvage pathway - WP3580 (Homo sapiens)
- Non-canonical Wnt pathway - WP215 (Danio rerio)
- Sphingolipid metabolism in senescence - WP5121 (Homo sapiens)
- Hematopoietic stem cell gene regulation by GABP alpha/beta complex - WP3657 (Homo sapiens)
- Blood clotting cascade - WP272 (Homo sapiens)
- Cardiac progenitor differentiation - WP2406 (Homo sapiens)
- Glycolysis in senescence - WP5049 (Homo sapiens)
- Carnosine metabolism of glial cells - WP5313 (Homo sapiens)
- Nucleotide excision repair - WP4753 (Homo sapiens)
- Base excision repair - WP4752 (Homo sapiens)
- Wnt signaling pathway and pluripotency - WP1288 (Rattus norvegicus)
- Kallmann syndrome - WP5074 (Homo sapiens)
- Primary ovarian insufficiency - WP5316 (Homo sapiens)
- Kennedy pathway from sphingolipids - WP3933 (Homo sapiens)
- Acute myeloid leukemia - WP5293 (Homo sapiens)
- Ras signaling - WP4223 (Homo sapiens)
- lncRNA in canonical Wnt signaling and colorectal cancer - WP4258 (Homo sapiens)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- Wnt signaling - WP428 (Homo sapiens)
- Clear cell renal cell carcinoma pathways - WP4018 (Homo sapiens)
- Cell cycle - WP179 (Homo sapiens)
- Osteoblast differentiation and related diseases - WP4787 (Homo sapiens)
- Transcriptional activation by NRF2 in response to phytochemicals - WP3 (Homo sapiens)
- EGFR tyrosine kinase inhibitor resistance - WP4806 (Homo sapiens)
- Hippo-YAP signaling - WP4537 (Homo sapiens)
- Vitamin K metabolism and activation of dependent proteins - WP5186 (Homo sapiens)
- TCA cycle (plant) - WP3009 (Oryza sativa)
- Warburg effect modulated by deubiquitinating enzymes and their substrates - WP5216 (Homo sapiens)
- D-arginine and D-ornithine metabolism - WP1642 (Mycobacterium tuberculosis)
- Diet-dependent trimethylamine/trimethylamine N-oxide metabolism - WP5219 (Homo sapiens)
- Osteoblast signaling - WP227 (Rattus norvegicus)
- Pantothenate and coenzyme A biosynthesis - WP462 (Saccharomyces cerevisiae)
- Nuclear receptors meta-pathway - WP2882 (Homo sapiens)
- Nicotine effect on chromaffin cells - WP1603 (Homo sapiens)
- Osteoclast signaling - WP12 (Homo sapiens)
- Pre-implantation embryo - WP3527 (Homo sapiens)
- Glycerophospholipid biosynthetic pathway - WP2533 (Homo sapiens)
- Comprehensive IL-17A signaling - WP5242 (Mus musculus)
- Aryl hydrocarbon receptor pathway - WP2586 (Homo sapiens)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4719 (Homo sapiens)
- Integrated cancer pathway - WP1971 (Homo sapiens)
- VEGF-receptor signal transduction - WP1965 (Rattus norvegicus)
- Glucocorticoid effect on target gene expression - WP1963 (Rattus norvegicus)
- Cori cycle - WP1946 (Homo sapiens)
- Mechanisms associated with pluripotency - WP1763 (Mus musculus)
- TP53 network - WP1742 (Homo sapiens)
- Iron homeostasis - WP1596 (Mus musculus)
- Folate-alcohol and cancer pathway hypotheses - WP1589 (Homo sapiens)
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559 (Homo sapiens)
- Metapathway signal transduction - WP1546 (Caenorhabditis elegans)
- MicroRNAs in cardiomyocyte hypertrophy - WP1544 (Homo sapiens)
- Energy metabolism - WP1541 (Homo sapiens)
- Flavonoid biosynthesis - WP1538 (Arabidopsis thaliana)
- miRNA regulation of DNA damage response - WP1530 (Homo sapiens)
- Regulation of cardiac hypertrophy by miR-208 - WP1526 (Mus musculus)
- Oxidative damage response - WP1496 (Mus musculus)
- Glycine metabolism - WP1495 (Homo sapiens)
- Opioid receptor pathways - WP5093 (Homo sapiens)
- Dopaminergic neurogenesis - WP2855 (Homo sapiens)
- AGE/RAGE pathway - WP2324 (Homo sapiens)
- Heart development - WP2067 (Mus musculus)
- Nicotine effect on dopaminergic neurons - WP1602 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Mitochondrial long chain fatty acid beta-oxidation - WP368 (Homo sapiens)
- Parkinson's disease - WP3638 (Mus musculus)
- Target of rapamycin signaling - WP1471 (Homo sapiens)
- Photosynthetic carbon reduction - WP1461 (Arabidopsis thaliana)
- Serotonin transporter activity - WP1455 (Homo sapiens)
- VEGFA-VEGFR2 signaling - WP3888 (Homo sapiens)
- Apoptosis modulation by HSP70 - WP384 (Homo sapiens)
- Osteoblast signaling - WP322 (Homo sapiens)
- Notch signaling - WP268 (Homo sapiens)
- Small ligand GPCRs - WP247 (Homo sapiens)
- Response regulator aspartate phosphatase interactions - WP1466 (Bacillus subtilis)
- Pyrimidine metabolism - WP4022 (Homo sapiens)
- mRNA processing - WP411 (Homo sapiens)
- Eukaryotic transcription initiation - WP405 (Homo sapiens)
- Fas ligand pathway and stress induction of heat shock proteins - WP314 (Homo sapiens)
- Nuclear receptors in lipid metabolism and toxicity - WP299 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP289 (Homo sapiens)
- S1P receptor signal transduction - WP26 (Homo sapiens)
- Osteopontin signaling - WP1434 (Homo sapiens)
- Homologous recombination - WP186 (Homo sapiens)
- Integrin-mediated cell adhesion - WP185 (Homo sapiens)
- Bone morphogenic protein signaling and regulation - WP1425 (Homo sapiens)
- Pentose phosphate metabolism - WP134 (Homo sapiens)
- Translation factors - WP107 (Homo sapiens)
- TGF-beta receptor signaling - WP560 (Homo sapiens)
- Biogenic amine synthesis - WP550 (Homo sapiens)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- Hypertrophy model - WP516 (Homo sapiens)
- Sulfation biotransformation reaction - WP692 (Homo sapiens)
- Glucose homeostasis - WP661 (Homo sapiens)
- Abscisic acid biosynthesis - WP626 (Arabidopsis thaliana)
- Flower development - WP618 (Arabidopsis thaliana)
- Glycogen synthesis and degradation - WP500 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP98 (Homo sapiens)
- Pyrimidine ribonucleotide salvage pathways - WP95 (Saccharomyces cerevisiae)
- Orexin receptor pathway - WP5094 (Homo sapiens)
- Omega-9 fatty acid synthesis - WP4351 (Mus musculus)
- Eicosanoid metabolism via lipoxygenases (LOX) - WP4348 (Mus musculus)
- Fructose metabolism in proximal tubules - WP3894 (Rattus norvegicus)
- Bacterial ceramide synthesis - WP5271 (Caulobacter vibrioides)
- Serotonin receptor 4/6/7 and NR3C signaling - WP734 (Homo sapiens)
- Serotonin receptor 2 and ELK-SRF/GATA4 signaling - WP732 (Homo sapiens)
- Serotonin HTR1 group and FOS pathway - WP722 (Homo sapiens)
- Serotonin transporter activity - WP3138 (Bos taurus)
- Serotonin receptor 4/6/7 and NR3C signaling - WP3272 (Bos taurus)
- Serotonin receptor 2 and ELK-SRF / GATA4 signaling - WP3242 (Bos taurus)
- Serotonin receptor 2 and STAT3 signaling - WP3115 (Bos taurus)
- Serotonin receptor 2 and STAT3 signaling - WP2079 (Mus musculus)
- IL-9 signaling pathway - WP10 (Mus musculus)
- IL-6 signaling pathway - WP135 (Rattus norvegicus)
- Metabolic pathways of fibroblasts - WP5312 (Homo sapiens)
- Mitochondrial complex I inhibition leading to parkinsonian motor deficits - WP4945 (Homo sapiens)
- Cysteine biosynthesis from homoserine - WP256 (Saccharomyces cerevisiae)
- Meiotic recombination genes - WP377 (Saccharomyces cerevisiae)
- Osteoclast signaling - WP890 (Pan troglodytes)
- GPCRs, class A rhodopsin-like - WP473 (Rattus norvegicus)
- Pyruvate dehydrogenase pathway - WP214 (Saccharomyces cerevisiae)
- Colanic acid building blocks biosynthesis - WP121 (Saccharomyces cerevisiae)
- Retinol metabolism - WP5188 (Homo sapiens)
- Inclusion body myositis - WP5120 (Homo sapiens)
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868 (Homo sapiens)
- Fatty acid biosynthesis - WP568 (Drosophila melanogaster)
- Fatty acid biosynthesis - WP504 (Rattus norvegicus)
- Fatty acid biosynthesis - WP38 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP357 (Homo sapiens)
- Fatty acid biosynthesis - WP336 (Mus musculus)
- Fatty acid biosynthesis - WP1020 (Bos taurus)
- Glycerophospholipid biosynthetic pathway - WP3198 (Bos taurus)
- Wnt signaling pathway and pluripotency - WP779 (Gallus gallus)
- ATM signaling pathway - WP654 (Rattus norvegicus)
- Glycerol teichoic acid biosynthesis - WP563 (Saccharomyces cerevisiae)
- PtdIns(4,5)P2 in cytokinesis pathway - WP5199 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- GDNF/RET signaling axis - WP4830 (Homo sapiens)
- GDNF/RET signaling axis - WP4820 (Mus musculus)
- Oxidative stress and redox pathway - WP4466 (Mus musculus)
- Metabolism of tetrahydrocannabinol (THC) - WP4174 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP3233 (Bos taurus)
- Cardiac progenitor differentiation - WP3127 (Bos taurus)
- Primary carbon metabolism - WP2859 (Populus trichocarpa)
- Pentose phosphate pathway - WP282 (Rattus norvegicus)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2573 (Mus musculus)
- Cardiolipin biosynthesis - WP2208 (Oryza sativa)
- DNA replication - WP192 (Caenorhabditis elegans)
- Oxidation by cytochrome P450 - WP1274 (Mus musculus)
- Translation factors - WP110 (Caenorhabditis elegans)
- Oxidation by cytochrome P450 - WP1077 (Bos taurus)
- Pentose phosphate pathway - WP1028 (Bos taurus)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4346 (Mus musculus)
- Phospholipid biosynthesis - WP9 (Saccharomyces cerevisiae)
- Heme biosynthesis - WP561 (Homo sapiens)
- TCA cycle in senescence - WP5050 (Homo sapiens)
- Deregulation of renin-angiotensin system by SARS-CoV infection - WP4965 (Mus musculus)
- Sphingolipid metabolism: integrated pathway - WP4726 (Homo sapiens)
- Omega-9 fatty acid synthesis - WP4724 (Homo sapiens)
- Omega-3 / omega-6 fatty acid synthesis - WP4723 (Homo sapiens)
- Glycerolipids and glycerophospholipids - WP4722 (Homo sapiens)
- Eicosanoid metabolism via lipooxygenases (LOX) - WP4721 (Homo sapiens)
- Eicosanoid metabolism via cytochrome P450 monooxygenases pathway - WP4720 (Homo sapiens)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4718 (Homo sapiens)
- Sphingolipid metabolism (integrated pathway) - WP4690 (Mus musculus)
- Omega-3 / omega-6 fatty acid synthesis - WP4350 (Mus musculus)
- Eicosanoid metabolism via cytochrome P450 monooxygenases - WP4349 (Mus musculus)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4347 (Mus musculus)
- Glycerolipids and glycerophospholipids - WP4345 (Mus musculus)
- Sphingolipid metabolism overview - WP4344 (Mus musculus)
- Fatty acid beta-oxidation 1 - WP39 (Drosophila melanogaster)
- De novo biosynthesis of pyrimidine deoxyribonucleotides - WP36 (Saccharomyces cerevisiae)
- Pregnane X receptor pathway - WP2876 (Homo sapiens)
- Triglyceride biosynthesis - WP266 (Saccharomyces cerevisiae)
- Heme biosynthesis - WP18 (Mus musculus)
- Eicosanoid synthesis - WP167 (Homo sapiens)
- Fatty acid elongation, unsaturated - WP16 (Saccharomyces cerevisiae)
- Selenium micronutrient network - WP15 (Homo sapiens)
- Fatty acid beta-oxidation - WP143 (Homo sapiens)
- Fatty acid beta-oxidation - WP1269 (Mus musculus)
- Triacylglyceride synthesis - WP782 (Gallus gallus)
- Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists - WP5273 (Homo sapiens)
- COVID-19 and endothelial cell senescence - WP5256 (Homo sapiens)
- Mitochondrial beta-oxidation - WP5241 (Homo sapiens)
- Lac-Phe pathway - WP5240 (Mus musculus)
- Clock-controlled autophagy in bone metabolism - WP5205 (Homo sapiens)
- Pro-survival signaling of neuroprotectin D1 - WP5182 (Homo sapiens)
- Arachidonic acid (AA, ARA) oxylipin metabolism - WP5155 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP385 (Mus musculus)
- Myometrial relaxation and contraction pathways - WP3276 (Bos taurus)
- Myometrial relaxation and contraction pathways - WP140 (Rattus norvegicus)
- Notch signaling pathway - WP1232 (Anopheles gambiae)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- Vitamin D in inflammatory diseases - WP4482 (Homo sapiens)
- Resistin as a regulator of inflammation - WP4481 (Homo sapiens)
- TLR4 signaling and tolerance - WP3851 (Homo sapiens)
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling - WP3850 (Homo sapiens)
- Overview of nanoparticle effects - WP3287 (Homo sapiens)
- PDGF pathway - WP2526 (Homo sapiens)
- Non-classical role of vitamin D - WP5133 (Homo sapiens)
- Steroid biosynthesis - WP1024 (Bos taurus)
- Retinoblastoma gene in cancer - WP3206 (Bos taurus)
- Glycolysis and gluconeogenesis - WP1567 (Mycobacterium tuberculosis)
- Actin cytoskeleton regulation - WP1062 (Bos taurus)
- FAS pathway and stress induction of HSP regulation - WP1019 (Bos taurus)
- Selenium micronutrient network - WP3257 (Bos taurus)
- Blood clotting cascade - WP3251 (Bos taurus)
- Vitamin B12 metabolism - WP3193 (Bos taurus)
- Selenium micronutrient network - WP1310 (Rattus norvegicus)
- Selenium micronutrient network - WP1272 (Mus musculus)
- Tryptophan degradation via kynurenine - WP452 (Saccharomyces cerevisiae)
- Allograft rejection - WP2328 (Homo sapiens)
- Cells and molecules involved in local acute inflammatory response - WP4493 (Homo sapiens)
- Microglia pathogen phagocytosis pathway - WP3937 (Homo sapiens)
- Regulation of actin cytoskeleton - WP523 (Mus musculus)
- Biogenic amine synthesis - WP125 (Drosophila melanogaster)
- ABA biosynthesis - WP2626 (Solanum lycopersicum)
- ID signaling pathway - WP934 (Pan troglodytes)
- ID signaling pathway - WP512 (Mus musculus)
- Leukocyte-intrinsic Hippo pathway functions - WP4542 (Homo sapiens)
- DNA IR-damage and cellular response via ATR - WP4016 (Homo sapiens)
- ID signaling pathway - WP397 (Rattus norvegicus)
- TGF-beta signaling pathway - WP366 (Homo sapiens)
- ID signaling pathway - WP1168 (Canis familiaris)
- Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex - WP4884 (Homo sapiens)
- miR-222 in exercise-induced cardiac growth - WP3938 (Homo sapiens)
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
- Aryl hydrocarbon receptor pathway - WP2873 (Homo sapiens)
- GDNF signaling - WP5143 (Homo sapiens)
- SARS-CoV-2 and ACE2 receptor: molecular mechanisms - WP4883 (Homo sapiens)
- Wnt signaling pathway - WP980 (Bos taurus)
- Wnt signaling pathway - WP539 (Mus musculus)
- LDLRAD4 and what we know about it - WP4904 (Homo sapiens)
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
- Wnt signaling pathway - WP375 (Rattus norvegicus)
- BDNF pathway - WP2152 (Mus musculus)
- Insulin signaling - WP481 (Homo sapiens)
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
- Photodynamic therapy-induced AP-1 survival signaling - WP3611 (Homo sapiens)
- MAPK signaling pathway - WP1114 (Canis familiaris)
- Cell cycle - WP1083 (Bos taurus)
- Triacylglyceride synthesis - WP1013 (Bos taurus)
- Wnt signaling pathway and pluripotency - WP1010 (Bos taurus)
- Arginine biosynthesis - WP275 (Saccharomyces cerevisiae)
- Neuroinflammation and glutamatergic signaling - WP5083 (Homo sapiens)
- Serine metabolism - WP4688 (Homo sapiens)
- Long-day flowering time pathway - WP622 (Arabidopsis thaliana)
- Cell differentiation - index - WP2029 (Homo sapiens)
- Spinal cord injury - WP2433 (Rattus norvegicus)
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
- Linoleic acid oxylipin metabolism - WP5137 (Homo sapiens)
- nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell - WP5027 (Homo sapiens)
- Beta-oxidation of unsaturated fatty acids - WP471 (Caenorhabditis elegans)
- Trehalose degradation, low osmolarity - WP70 (Saccharomyces cerevisiae)
- Cori cycle - WP3114 (Bos taurus)
- Male infertility - WP4673 (Homo sapiens)
- Parkin-ubiquitin proteasomal system pathway - WP2359 (Homo sapiens)
- Vitamin D receptor pathway - WP2877 (Homo sapiens)
- Nod-like receptor (NLR) signaling pathway - WP799 (Gallus gallus)
- Nicotine metabolism in liver cells - WP1600 (Homo sapiens)
- Prostaglandin and leukotriene metabolism in senescence - WP5122 (Homo sapiens)
- Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway - WP5113 (Homo sapiens)
- Gut-liver indole metabolism - WP3627 (Homo sapiens)
- Role of carnosine in muscle contraction - WP4486 (Homo sapiens)
- Hormonal control of pubertal growth spurt - WP4194 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
- Oxidation by cytochrome P450 - WP43 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2572 (Homo sapiens)
- Arrhythmogenic right ventricular cardiomyopathy - WP2118 (Homo sapiens)
- Progeria-associated lipodystrophy - WP5103 (Homo sapiens)
- Familial partial lipodystrophy - WP5102 (Homo sapiens)
- Congenital generalized lipodystrophy - WP5101 (Homo sapiens)
- Ketogenesis and ketolysis - WP4742 (Homo sapiens)
- Biotin metabolism, including IMDs - WP5031 (Homo sapiens)
- Hypoxia-dependent proliferation of myoblasts - WP5024 (Mus musculus)
- EGF/EGFR signaling pathway - WP978 (Bos taurus)
- Distal convoluted tubule 1 (DCT1) cell - WP4183 (Mus musculus)
- NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence - WP5046 (Homo sapiens)
- NAD+ metabolism - WP3644 (Homo sapiens)
- Endoplasmic reticulum stress response in coronavirus infection - WP4861 (Homo sapiens)
- Beta-oxidation of unsaturated fatty acids - WP418 (Rattus norvegicus)
- Beta-oxidation meta-pathway - WP372 (Rattus norvegicus)
- NAD+ biosynthetic pathways - WP3645 (Homo sapiens)
- miR-222 in exercise-induced cardiac growth - WP2928 (Mus musculus)
- Ovarian infertility - WP273 (Mus musculus)
- Fatty acid beta-oxidation meta-pathway - WP209 (Caenorhabditis elegans)
- Soluble ACE2-mediated cell entry of SARS-CoV-2 - WP5076 (Homo sapiens)
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065 (Homo sapiens)
- Flowering time pathway - WP2603 (Beta vulgaris)
- Valine biosynthesis - WP2 (Saccharomyces cerevisiae)
- Toll-like receptor signaling pathway - WP1384 (Danio rerio)
- Hepatocyte growth factor receptor signaling - WP94 (Rattus norvegicus)
- Hepatocyte growth factor receptor signaling - WP927 (Pan troglodytes)
- Hepatocyte growth factor receptor signaling - WP313 (Homo sapiens)
- Hepatocyte growth factor receptor signaling - WP1046 (Bos taurus)
- Cytokinin-auxin interactions in plant development - WP2945 (Arabidopsis thaliana)
- Polar auxin transport - WP2941 (Arabidopsis thaliana)
- Wnt signaling pathway - WP1135 (Canis familiaris)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Glucosinolate biosynthesis from branched-chain amino acid - WP4599 (Arabidopsis thaliana)
- Glucosinolate biosynthesis from methionine - WP4597 (Arabidopsis thaliana)
- Mitochondrial long chain fatty acid beta-oxidation - WP448 (Caenorhabditis elegans)
- Ketone bodies synthesis and degradation - WP427 (Caenorhabditis elegans)
- Nodal signaling pathway - WP341 (Danio rerio)
- UDP-L-arabinose biosynthesis I from UDP-xylose - WP3015 (Arabidopsis thaliana)
- Triacylglyceride synthesis - WP212 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Eukaryotic transcription initiation - WP830 (Gallus gallus)
- Vulval development and SynMuv - WP680 (Caenorhabditis elegans)
- Proteasome degradation - WP470 (Caenorhabditis elegans)
- Glycogen metabolism - WP436 (Caenorhabditis elegans)
- ERK1-ERK2 MAPK cascade - WP402 (Danio rerio)
- DNA IR-double strand breaks and cellular response via ATM - WP3959 (Homo sapiens)
- Leptin-insulin signaling overlap - WP3935 (Homo sapiens)
- Caffeine and theobromine metabolism - WP3633 (Homo sapiens)
- Pentose phosphate pathway - WP312 (Caenorhabditis elegans)
- Role of lipid metabolism - WP2915 (Caenorhabditis elegans)
- Differentiation of white and brown adipocyte - WP2895 (Homo sapiens)
- Mesodermal commitment pathway - WP2857 (Homo sapiens)
- Programmed cell death and cell engulfment - WP2829 (Caenorhabditis elegans)
- Sucrose metabolism - WP2623 (Arabidopsis thaliana)
- Starch metabolism - WP2622 (Arabidopsis thaliana)
- ER stress-unfolded protein response (UPRer) - WP2578 (Caenorhabditis elegans)
- EGF signaling in vulval development - WP2221 (Caenorhabditis elegans)
- Notch signaling in vulval development - WP2220 (Caenorhabditis elegans)
- Eukaryotic transcription initiation - WP177 (Drosophila melanogaster)
- Cell division: first embryonic mitosis - WP1411 (Caenorhabditis elegans)
- Monoamine GPCRs - WP1389 (Danio rerio)
- Fatty acid beta-oxidation 1 - WP126 (Caenorhabditis elegans)
- Pentose phosphate pathway - WP1231 (Anopheles gambiae)
- Cholesterol biosynthesis - WP1070 (Bos taurus)
- Eukaryotic transcription initiation - WP1066 (Bos taurus)
- Homologous recombination - WP1036 (Bos taurus)
- Programmed cell death - WP367 (Caenorhabditis elegans)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP3171 (Bos taurus)
- De novo biosynthesis of purine nucleotides - WP203 (Saccharomyces cerevisiae)
- Eukaryotic transcription initiation - WP518 (Caenorhabditis elegans)
- Nitric oxide metabolism in cystic fibrosis - WP4947 (Homo sapiens)
- Regulation of Wnt / B-catenin signaling by small molecule compounds - WP3664 (Homo sapiens)
- Crystal toxin triggered necrosis pathway - WP3648 (Caenorhabditis elegans)
- Folate biosynthesis - WP2360 (Bacillus subtilis)
- Programmed cell death and cell engulfment - WP2231 (Caenorhabditis elegans)
- Ascaroside biosynthesis - WP2224 (Caenorhabditis elegans)
- Wnt signaling in cell polarity - WP2222 (Caenorhabditis elegans)
- Alpha 6 beta 4 signaling pathway - WP985 (Bos taurus)
- Wnt signaling pathway and pluripotency - WP723 (Mus musculus)
- Pentose phosphate pathway - WP63 (Mus musculus)
- EGFR1 signaling pathway - WP572 (Mus musculus)
- FAS pathway and stress induction of HSP regulation - WP571 (Mus musculus)
- Signal transduction of S1P receptor - WP57 (Mus musculus)
- Eukaryotic transcription initiation - WP567 (Mus musculus)
- Calcium regulation in cardiac cells - WP553 (Mus musculus)
- Exercise-induced circadian regulation - WP544 (Mus musculus)
- Mapk signaling pathway - WP493 (Mus musculus)
- Alpha 6 beta 4 integrin signaling pathway - WP488 (Mus musculus)
- Blood clotting cascade - WP460 (Mus musculus)
- Inflammatory response pathway - WP458 (Mus musculus)
- Canonical NF-kB pathway - WP4562 (Homo sapiens)
- GPCRs, class B secretin-like - WP456 (Mus musculus)
- Osteoclast signaling - WP454 (Mus musculus)
- IL-2 signaling pathway - WP450 (Mus musculus)
- Matrix metalloproteinases - WP441 (Mus musculus)
- PDGFR-alpha and STMN1 cooperate to exacerbate cytotoxic effects of vinblastine - WP4398 (Mus musculus)
- TCA cycle - WP434 (Mus musculus)
- Eicosanoid lipid synthesis map - WP4335 (Mus musculus)
- Kit receptor signaling pathway - WP407 (Mus musculus)
- Mitochondrial long chain fatty acid beta-oxidation - WP401 (Mus musculus)
- IL-6 signaling pathway - WP387 (Mus musculus)
- Robo4 and VEGF signaling pathways crosstalk - WP3864 (Mus musculus)
- Prostaglandin synthesis and regulation - WP374 (Mus musculus)
- IL-3 signaling pathway - WP373 (Mus musculus)
- IL-1 signaling pathway - WP37 (Mus musculus)
- BMP signaling pathway in eyelid development - WP3663 (Mus musculus)
- Interleukin-1 induced activation of NF-kB - WP3656 (Homo sapiens)
- GPCRs, small ligand - WP353 (Mus musculus)
- GPCRs, class C metabotropic glutamate, pheromone - WP327 (Mus musculus)
- Aryl hydrocarbon receptor pathway - WP3205 (Bos taurus)
- Eicosanoid synthesis - WP318 (Mus musculus)
- Interleukin-1 (IL-1) structural pathway - WP3178 (Bos taurus)
- IL-17 signaling pathway - WP3176 (Bos taurus)
- Glycogen metabolism - WP317 (Mus musculus)
- Translation factors - WP307 (Mus musculus)
- IL-7 signaling pathway - WP297 (Mus musculus)
- Electron transport chain - WP295 (Mus musculus)
- miR302-367 promoting cardiomyocyte proliferation - WP2904 (Mus musculus)
- Wnt signaling - Q neuroblast migration - WP2888 (Caenorhabditis elegans)
- Delta-Notch signaling pathway - WP265 (Mus musculus)
- Acetylcholine synthesis - WP264 (Caenorhabditis elegans)
- Wnt signaling - WP235 (Caenorhabditis elegans)
- GPCRs, peptide - WP234 (Mus musculus)
- G protein signaling pathways - WP232 (Mus musculus)
- Neural crest differentiation - WP2074 (Mus musculus)
- Hypertrophy model - WP202 (Mus musculus)
- Complement activation, classical pathway - WP200 (Mus musculus)
- GPCRs, class A rhodopsin-like - WP189 (Mus musculus)
- Apoptosis modulation by HSP70 - WP166 (Mus musculus)
- IL-5 signaling pathway - WP151 (Mus musculus)
- GPCRs, orphan - WP1398 (Mus musculus)
- GPCRs, odorant - WP1397 (Mus musculus)
- GPCRs, non-odorant - WP1396 (Mus musculus)
- IL-4 signaling pathway - WP1376 (Danio rerio)
- Endochondral ossification - WP1270 (Mus musculus)
- SIDS susceptibility pathways - WP1266 (Mus musculus)
- Delta-Notch signaling pathway - WP1180 (Canis familiaris)
- Hedgehog signaling pathway - WP116 (Mus musculus)
- Selenium metabolism / selenoproteins - WP108 (Mus musculus)
- Methylation pathways - WP704 (Homo sapiens)
- Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) - WP688 (Homo sapiens)
- DNA mismatch repair - WP531 (Homo sapiens)
- GPCRs, class C metabotropic glutamate, pheromone - WP501 (Homo sapiens)
- DNA repair pathways, full network - WP4946 (Homo sapiens)
- Direct reversal repair - WP4931 (Homo sapiens)
- Mitochondrial complex IV assembly - WP4922 (Homo sapiens)
- Mitochondrial complex II assembly - WP4920 (Homo sapiens)
- Conversion of angiotensinogen to angiotensin II - WP4818 (Homo sapiens)
- Amino acid metabolism pathway excerpt: histidine catabolism extension - WP4661 (Homo sapiens)
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
- Neural crest cell migration during development - WP4564 (Homo sapiens)
- GPCRs, class A rhodopsin-like - WP455 (Homo sapiens)
- Acrylamide biotransformation and exposure biomarkers - WP4233 (Homo sapiens)
- NO/cGMP/PKG mediated neuroprotection - WP4008 (Homo sapiens)
- BMP signaling in eyelid development - WP3927 (Homo sapiens)
- TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition - WP3859 (Homo sapiens)
- Toll-like receptor signaling related to MyD88 - WP3858 (Homo sapiens)
- Physico-chemical features and toxicity-associated pathways - WP3680 (Homo sapiens)
- Tgif disruption of Shh signaling - WP3674 (Homo sapiens)
- lncRNA-mediated mechanisms of therapeutic resistance - WP3672 (Homo sapiens)
- Interactions between LOXL4 and oxidative stress pathway - WP3670 (Homo sapiens)
- Metabolism of dichloroethylene by CYP450 - WP3666 (Homo sapiens)
- Biochemical pathways: part I - WP3604 (Homo sapiens)
- Lipid particles composition - WP3601 (Homo sapiens)
- Circadian rhythm genes - WP3594 (Homo sapiens)
- GPCRs, class B secretin-like - WP334 (Homo sapiens)
- Glucocorticoid receptor pathway - WP2880 (Homo sapiens)
- Constitutive androstane receptor pathway - WP2875 (Homo sapiens)
- Hair follicle development: organogenesis - part 2 of 3 - WP2839 (Homo sapiens)
- Felbamate metabolism - WP2816 (Homo sapiens)
- Cardiac hypertrophic response - WP2795 (Homo sapiens)
- Aripiprazole metabolic pathway - WP2640 (Homo sapiens)
- Sulindac metabolic pathway - WP2542 (Homo sapiens)
- Colchicine metabolic pathway - WP2536 (Homo sapiens)
- Diclofenac metabolic pathway - WP2491 (Homo sapiens)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453 (Homo sapiens)
- Gastric cancer network 2 - WP2363 (Homo sapiens)
- Gastric cancer network 1 - WP2361 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291 (Homo sapiens)
- Fatty acid omega-oxidation - WP206 (Homo sapiens)
- Cell differentiation - expanded index - WP2023 (Homo sapiens)
- SRF and miRs in smooth muscle differentiation and proliferation - WP1991 (Homo sapiens)
- Matrix metalloproteinases - WP129 (Homo sapiens)
- GPCRs, other - WP117 (Homo sapiens)
- Cytokines and inflammatory response - WP997 (Bos taurus)
- EPO receptor signaling - WP996 (Bos taurus)
- Prostaglandin synthesis and regulation - WP995 (Bos taurus)
- Methylation pathways - WP992 (Bos taurus)
- GPCRs, other - WP990 (Bos taurus)
- Hypertrophy model - WP982 (Bos taurus)
- Nuclear receptors in lipid metabolism and toxicity - WP981 (Bos taurus)
- Complement activation, classical pathway - WP977 (Bos taurus)
- IL-9 signaling pathway - WP974 (Bos taurus)
- IL-2 signaling pathway - WP973 (Bos taurus)
- Eicosanoid synthesis - WP972 (Bos taurus)
- Small ligand GPCRs - WP971 (Bos taurus)
- Fatty acid omega-oxidation - WP970 (Bos taurus)
- Striated muscle contraction - WP969 (Bos taurus)
- IL-5 signaling pathway - WP968 (Bos taurus)
- Heme biosynthesis - WP967 (Bos taurus)
- Translation factors - WP965 (Bos taurus)
- Osteoblast signaling - WP956 (Pan troglodytes)
- Glycogen metabolism - WP955 (Pan troglodytes)
- Cholesterol biosynthesis - WP952 (Pan troglodytes)
- Nuclear receptors - WP950 (Pan troglodytes)
- Eukaryotic transcription initiation - WP948 (Pan troglodytes)
- Delta-Notch signaling pathway - WP946 (Pan troglodytes)
- G13 signaling pathway - WP945 (Pan troglodytes)
- Matrix metalloproteinases - WP942 (Pan troglodytes)
- G protein signaling pathways - WP931 (Pan troglodytes)
- Calcium regulation in cardiac cells - WP923 (Pan troglodytes)
- Statin pathway - WP921 (Pan troglodytes)
- ACE inhibitor pathway - WP915 (Pan troglodytes)
- Notch signaling pathway - WP912 (Pan troglodytes)
- Hedgehog signaling pathway - WP905 (Pan troglodytes)
- Wnt signaling pathway - WP899 (Pan troglodytes)
- Ketone bodies synthesis and degradation - WP898 (Pan troglodytes)
- Blood clotting cascade - WP887 (Pan troglodytes)
- Kit receptor signaling pathway - WP886 (Pan troglodytes)
- Cytokines and inflammatory response - WP879 (Pan troglodytes)
- EPO receptor signaling - WP878 (Pan troglodytes)
- EGFR1 signaling pathway - WP860 (Pan troglodytes)
- Eicosanoid synthesis - WP854 (Pan troglodytes)
- Fatty acid omega-oxidation - WP852 (Pan troglodytes)
- Heme biosynthesis - WP848 (Pan troglodytes)
- Monoterpene biosynthesis pathway in mint - WP4701 (Vitis vinifera)
- Central carbon metabolism - WP3583 (Escherichia coli)
- T cell receptor and co-stimulatory signaling - WP3282 (Bos taurus)
- Heart development - WP3280 (Bos taurus)
- Globo sphingolipid metabolism - WP3278 (Bos taurus)
- Oncostatin M signaling pathway - WP3277 (Bos taurus)
- Fluoropyrimidine activity - WP3275 (Bos taurus)
- Neural crest differentiation - WP3273 (Bos taurus)
- Codeine and morphine metabolism - WP3270 (Bos taurus)
- Nicotine activity on chromaffin cells - WP3255 (Bos taurus)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP3252 (Bos taurus)
- Cardiac hypertrophic response - WP3250 (Bos taurus)
- Integrated cancer pathway - WP3244 (Bos taurus)
- Endoderm differentiation - WP3240 (Bos taurus)
- Thyroxine (thyroid hormone) production - WP3237 (Bos taurus)
- TWEAK signaling pathway - WP3236 (Bos taurus)
- Sulfation biotransformation reaction - WP3234 (Bos taurus)
- Sphingolipid metabolism - WP3232 (Bos taurus)
- Exercise-induced circadian regulation - WP3230 (Bos taurus)
- NAD biosynthesis II from tryptophan - WP3228 (Bos taurus)
- Thyroid stimulating hormone (TSH) signaling pathway - WP3227 (Bos taurus)
- Aryl hydrocarbon receptor - WP3226 (Bos taurus)
- Synaptic vesicle pathway - WP3224 (Bos taurus)
- ATM signaling pathway - WP3221 (Bos taurus)
- Ganglio sphingolipid metabolism - WP3219 (Bos taurus)
- Membrane trafficking - WP3212 (Bos taurus)
- Nucleotide metabolism - WP3211 (Bos taurus)
- Ectoderm differentiation - WP3208 (Bos taurus)
- Hydrochloric acid secretion in parietal cells - WP3204 (Bos taurus)
- Cell differentiation - index - WP3202 (Bos taurus)
- PDGF pathway - WP3200 (Bos taurus)
- Parkin-ubiquitin proteasomal system pathway - WP3199 (Bos taurus)
- Focal adhesion - WP3197 (Bos taurus)
- Dopaminergic neurogenesis - WP3196 (Bos taurus)
- Arrhythmogenic right ventricular cardiomyopathy - WP3195 (Bos taurus)
- Neurotransmitter release cycle - WP3192 (Bos taurus)
- TSLP signaling pathway - WP3191 (Bos taurus)
- Felbamate metabolism - WP3189 (Bos taurus)
- Colchicine metabolic pathway - WP3187 (Bos taurus)
- Spinal cord injury - WP3186 (Bos taurus)
- Nicotine metabolism - WP3185 (Bos taurus)
- Mesodermal commitment pathway - WP3183 (Bos taurus)
- Nicotine activity on dopaminergic neurons - WP3179 (Bos taurus)
- Microtubule cytoskeleton regulation - WP3177 (Bos taurus)
- Hematopoietic stem cell differentiation - WP3174 (Bos taurus)
- Biogenic amine synthesis - WP3168 (Bos taurus)
- Gastric cancer network 1 - WP3166 (Bos taurus)
- Neurotransmitter clearance in synaptic cleft - WP3165 (Bos taurus)
- Vitamin D metabolism - WP3162 (Bos taurus)
- Interleukin-11 signaling pathway - WP3159 (Bos taurus)
- Osteopontin signaling - WP3156 (Bos taurus)
- AMPK signaling - WP3154 (Bos taurus)
- Diclofenac metabolic pathway - WP3152 (Bos taurus)
- Sulindac metabolic pathway - WP3150 (Bos taurus)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP3149 (Bos taurus)
- Apoptosis modulation and signaling - WP3148 (Bos taurus)
- Glycine metabolism - WP3142 (Bos taurus)
- miRNA biogenesis - WP3140 (Bos taurus)
- Constitutive androstane receptor pathway - WP3131 (Bos taurus)
- Histone modifications - WP3123 (Bos taurus)
- Folate-alcohol and cancer pathway - WP3120 (Bos taurus)
- Polar auxin transport - WP2940 (Oryza sativa)
- Isoprenoid precursor biosynthesis in Pf apicoplasts - WP2918 (Plasmodium falciparum)
- IGF-1 signaling - WP2892 (Bos taurus)
- Growth hormone receptor (GHR) signaling - WP2891 (Bos taurus)
- Growth hormone (GH) signaling - WP2890 (Bos taurus)
- Glyoxylate, anapleurotic and succinyl CoA (GAS) pathway - WP2638 (Mycobacterium tuberculosis)
- Transcription initiation by sigma factors - WP2564 (Mycobacterium tuberculosis)
- NAD biosynthesis I from aspartate - WP2484 (Escherichia coli)
- Escherichia coli K-12 peripherome - WP2472 (Escherichia coli)
- Osteoblast signaling - WP238 (Mus musculus)
- Momilactone biosynthesis - WP2209 (Oryza sativa)
- Beta-alanine biosynthesis - WP2207 (Oryza sativa)
- Carotenoid biosynthesis - WP2205 (Zea mays)
- Ganglio sphingolipid metabolism - WP1423 (Homo sapiens)
- Glycogen metabolism - WP1189 (Canis familiaris)
- Cholesterol biosynthesis - WP1186 (Canis familiaris)
- Nuclear receptors - WP1184 (Canis familiaris)
- Eukaryotic transcription initiation - WP1182 (Canis familiaris)
- G13 signaling pathway - WP1179 (Canis familiaris)
- Matrix metalloproteinases - WP1176 (Canis familiaris)
- G protein signaling pathways - WP1165 (Canis familiaris)
- Calcium regulation in cardiac cells - WP1159 (Canis familiaris)
- Statin pathway - WP1157 (Canis familiaris)
- ACE inhibitor pathway - WP1151 (Canis familiaris)
- Notch signaling pathway - WP1148 (Canis familiaris)
- Hedgehog signaling pathway - WP1141 (Canis familiaris)
- Ketone bodies synthesis and degradation - WP1134 (Canis familiaris)
- Wnt signaling pathway and pluripotency - WP1129 (Canis familiaris)
- Blood clotting cascade - WP1122 (Canis familiaris)
- Kit receptor signaling pathway - WP1121 (Canis familiaris)
- Electron transport chain - WP1119 (Canis familiaris)
- Biogenic amine synthesis - WP1118 (Canis familiaris)
- Cytokines and inflammatory response - WP1113 (Canis familiaris)
- EPO receptor signaling - WP1112 (Canis familiaris)
- EGFR1 signaling pathway - WP1096 (Canis familiaris)
- IL-2 signaling pathway - WP1091 (Canis familiaris)
- Eicosanoid synthesis - WP1090 (Canis familiaris)
- S1P receptor signal transduction - WP1081 (Bos taurus)
- Osteoblast signaling - WP1074 (Bos taurus)
- Glycogen metabolism - WP1073 (Bos taurus)
- GPCRs, class A rhodopsin-like - WP1072 (Bos taurus)
- Integrin-mediated cell adhesion - WP1069 (Bos taurus)
- Nuclear receptors - WP1068 (Bos taurus)
- Endochondral ossification - WP1065 (Bos taurus)
- Notch signaling pathway - WP1064 (Bos taurus)
- G13 signaling pathway - WP1063 (Bos taurus)
- Matrix metalloproteinases - WP1060 (Bos taurus)
- GPCRs, class C metabotropic glutamate, pheromone - WP1051 (Bos taurus)
- G protein signaling pathways - WP1049 (Bos taurus)
- TGF-beta receptor signaling - WP1048 (Bos taurus)
- TGF-beta signaling pathway - WP1045 (Bos taurus)
- Calcium regulation in cardiac cell - WP1043 (Bos taurus)
- Inflammatory response pathway - WP1040 (Bos taurus)
- Acetylcholine synthesis - WP1034 (Bos taurus)
- ACE inhibitor pathway - WP1033 (Bos taurus)
- IL-3 signaling pathway - WP1031 (Bos taurus)
- Notch signaling pathway - WP1029 (Bos taurus)
- Glycolysis and gluconeogenesis - WP1027 (Bos taurus)
- B cell receptor signaling pathway - WP1025 (Bos taurus)
- Hedgehog signaling pathway - WP1022 (Bos taurus)
- Wnt signaling pathway - WP1016 (Bos taurus)
- Ketone bodies synthesis and degradation - WP1015 (Bos taurus)
- IL-7 signaling pathway - WP1012 (Bos taurus)
- TCR signaling pathway - WP1011 (Bos taurus)
- Osteoclast signaling - WP1007 (Bos taurus)
- GPCRs, class B secretin-like - WP1005 (Bos taurus)
- Electron transport chain - WP1002 (Bos taurus)
- De novo biosynthesis of pyrimidine ribonucleotides - WP92 (Saccharomyces cerevisiae)
- NAD biosynthesis - WP84 (Saccharomyces cerevisiae)
- Pentose phosphate pathway 2 - WP670 (Saccharomyces cerevisiae)
- Asparagine biosynthesis - WP67 (Saccharomyces cerevisiae)
- Mitochondrial tRNA synthetases - WP62 (Saccharomyces cerevisiae)
- Phenylalanine degradation - WP573 (Saccharomyces cerevisiae)
- De novo NAD biosynthesis - WP541 (Saccharomyces cerevisiae)
- Tyrosine biosynthesis - WP538 (Saccharomyces cerevisiae)
- Glycolysis and gluconeogenesis - WP515 (Saccharomyces cerevisiae)
- MAPK signaling pathway - WP510 (Saccharomyces cerevisiae)
- Glycogen catabolism - WP478 (Saccharomyces cerevisiae)
- Phosphatidic acid and phospholipid biosynthesis - WP472 (Saccharomyces cerevisiae)
- Purine fermentation - WP463 (Saccharomyces cerevisiae)
- Methionine degradation - WP46 (Saccharomyces cerevisiae)
- Serine biosynthesis - WP459 (Saccharomyces cerevisiae)
- Eukaryotic transcription initiation - WP425 (Saccharomyces cerevisiae)
- Threonine and methionine biosynthesis - WP423 (Saccharomyces cerevisiae)
- Histidine, purine, and pyrimidine superpathway - WP416 (Saccharomyces cerevisiae)
- Cell cycle and cell division - WP414 (Saccharomyces cerevisiae)
- Trehalose anabolism - WP398 (Saccharomyces cerevisiae)
- Riboflavin, FMN, and FAD biosynthesis - WP381 (Saccharomyces cerevisiae)
- Fatty acid elongation, saturated - WP380 (Saccharomyces cerevisiae)
- Pentose pathway, non-oxidative branch - WP379 (Saccharomyces cerevisiae)
- Sphingolipid metabolism - WP370 (Saccharomyces cerevisiae)
- Pentose phosphate pathway - WP369 (Saccharomyces cerevisiae)
- Isoleucine and valine biosynthesis - WP359 (Saccharomyces cerevisiae)
- Leucine degradation - WP354 (Saccharomyces cerevisiae)
- Protein modifications - WP346 (Saccharomyces cerevisiae)
- Glycine degradation - WP345 (Saccharomyces cerevisiae)
- Threonine biosynthesis - WP331 (Saccharomyces cerevisiae)
- Allantoin degradation - WP328 (Saccharomyces cerevisiae)
- Nucleotide metabolism - WP321 (Saccharomyces cerevisiae)
- Tryptophan degradation - WP301 (Saccharomyces cerevisiae)
- TCA cycle - detailed - WP296 (Saccharomyces cerevisiae)
- Polyamine biosynthesis - WP290 (Saccharomyces cerevisiae)
- Upiquinone Q prenylation - WP287 (Saccharomyces cerevisiae)
- Phenylalanine, tyrosine, and tryptophan biosynthesis - WP27 (Saccharomyces cerevisiae)
- Starch and cellulose biosynthesis - WP257 (Saccharomyces cerevisiae)
- Aerobic glycerol catabolism - WP224 (Saccharomyces cerevisiae)
- Ribose and deoxyribose phosphate metabolism - WP220 (Saccharomyces cerevisiae)
- Cytoplasmic tRNA synthetases - WP219 (Saccharomyces cerevisiae)
- Serine and glycine biosynthesis - WP218 (Saccharomyces cerevisiae)
- Isoleucine, leucine, and valine biosynthesis - WP198 (Saccharomyces cerevisiae)
- Glutathione biosynthesis - WP196 (Saccharomyces cerevisiae)
- Phenylalanine biosynthesis - WP194 (Saccharomyces cerevisiae)
- Glutamate biosynthesis superpathway - WP191 (Saccharomyces cerevisiae)
- P-cymene degradation - WP181 (Saccharomyces cerevisiae)
- Leucine biosynthesis - WP180 (Saccharomyces cerevisiae)
- Isoleucine degradation - WP178 (Saccharomyces cerevisiae)
- NAD salvage pathway - WP171 (Saccharomyces cerevisiae)
- Tryptophan biosynthesis - WP165 (Saccharomyces cerevisiae)
- UDP-N-acetylgalactosamine biosynthesis - WP159 (Saccharomyces cerevisiae)
- Aspartate biosynthesis - WP1518 (Saccharomyces cerevisiae)
- Fatty acid biosynthesis, initial steps - WP137 (Saccharomyces cerevisiae)
- Cholesterol biosynthesis - WP132 (Saccharomyces cerevisiae)
- DNA replication - WP13 (Saccharomyces cerevisiae)
- Homocysteine and cysteine interconversion - WP128 (Saccharomyces cerevisiae)
- UDP-glucose conversion - WP109 (Saccharomyces cerevisiae)
- Nuclear receptors - WP831 (Gallus gallus)
- Regulation of actin cytoskeleton - WP824 (Gallus gallus)
- Matrix metalloproteinases - WP823 (Gallus gallus)
- Inhibitor of DNA binding (ID) signaling pathway - WP815 (Gallus gallus)
- Notch signaling pathway - WP798 (Gallus gallus)
- mRNA processing - WP793 (Gallus gallus)
- Hedgehog signaling pathway - WP790 (Gallus gallus)
- Wnt signaling pathway - WP785 (Gallus gallus)
- Kit receptor signaling pathway - WP774 (Gallus gallus)
- MAPK signaling pathway - WP769 (Gallus gallus)
- Mitochondrial long chain fatty acid beta-oxidation - WP763 (Gallus gallus)
- Triacylglycerol biosynthesis - WP627 (Arabidopsis thaliana)
- Biosynthesis of gamma-aminobutyric acid (GABA) by polyamine oxidation - WP4232 (Arabidopsis thaliana)
- Glucose sensing and signaling - WP3860 (Arabidopsis thaliana)
- Toll, IMD, JAK/STAT pathways for immune response to pathogens - WP3856 (Anopheles gambiae)
- Genetic interactions between sugar and hormone signaling - WP3661 (Arabidopsis thaliana)
- TCA cycle (Krebs cycle) - WP2624 (Arabidopsis thaliana)
- Chlorophyll b degradation - WP2230 (Arabidopsis thaliana)
- Flower development: initiation - WP2108 (Arabidopsis thaliana)
- Linoleate biosynthesis - WP1996 (Arabidopsis thaliana)
- Eukaryotic transcription initiation - WP1238 (Anopheles gambiae)
- TCA cycle - WP1227 (Anopheles gambiae)
- Glycogen metabolism - WP835 (Gallus gallus)
- Cholesterol biosynthesis - WP833 (Gallus gallus)
- Delta-Notch signaling pathway - WP827 (Gallus gallus)
- G13 signaling pathway - WP826 (Gallus gallus)
- G protein signaling pathways - WP813 (Gallus gallus)
- Calcium regulation in cardiac cells - WP808 (Gallus gallus)
- ACE inhibitor pathway - WP801 (Gallus gallus)
- FAS pathway and stress induction of HSP regulation - WP788 (Gallus gallus)
- Ketone bodies synthesis and degradation - WP784 (Gallus gallus)
- Blood clotting cascade - WP775 (Gallus gallus)
- EPO receptor signaling - WP768 (Gallus gallus)
- EGFR1 signaling pathway - WP752 (Gallus gallus)
- Polyol pathway - WP690 (Homo sapiens)
- GPR40 pathway - WP3958 (Homo sapiens)
- Imatinib and chronic myeloid leukemia - WP3640 (Homo sapiens)
- T cell receptor and co-stimulatory signaling - WP2583 (Homo sapiens)
- NAD biosynthesis II (from tryptophan) - WP2485 (Homo sapiens)
- miRNA biogenesis - WP2338 (Homo sapiens)
- Neural crest differentiation - WP2064 (Homo sapiens)
- EPO receptor signaling - WP581 (Homo sapiens)
- Exercise-induced circadian regulation - WP410 (Homo sapiens)
- Wnt signaling pathway - WP97 (Drosophila melanogaster)
- Apoptosis modulation by HSP70 - WP963 (Pan troglodytes)
- Nod-like receptor (NLR) signaling pathway - WP914 (Pan troglodytes)
- FAS pathway and stress induction of HSP regulation - WP902 (Pan troglodytes)
- Heme biosynthesis - WP86 (Rattus norvegicus)
- IL-9 signaling pathway - WP8 (Rattus norvegicus)
- G protein signaling pathways - WP73 (Rattus norvegicus)
- Steroid biosynthesis - WP66 (Rattus norvegicus)
- Cardiovascular signaling - WP590 (Rattus norvegicus)
- Hedgehog signaling pathway - WP574 (Rattus norvegicus)
- IL-2 signaling pathway - WP569 (Rattus norvegicus)
- ACE inhibitor pathway - WP557 (Rattus norvegicus)
- Complement and coagulation cascades - WP547 (Rattus norvegicus)
- Cytoplasmic ribosomal proteins - WP540 (Caenorhabditis elegans)
- Translation factors - WP537 (Drosophila melanogaster)
- mRNA processing - WP529 (Rattus norvegicus)
- Mitochondrial unfolded-protein response - WP525 (Caenorhabditis elegans)
- G13 signaling pathway - WP520 (Rattus norvegicus)
- Proteasome degradation - WP519 (Mus musculus)
- Notch signaling pathway - WP517 (Rattus norvegicus)
- Biosynthesis of aldosterone and cortisol - WP508 (Rattus norvegicus)
- Hedgehog signaling pathway - WP492 (Drosophila melanogaster)
- Osteoclast - WP489 (Rattus norvegicus)
- Apoptosis modulation by HSP70 - WP487 (Rattus norvegicus)
- Cytoplasmic ribosomal proteins - WP477 (Homo sapiens)
- TNF-alpha NF-kB signaling pathway - WP457 (Rattus norvegicus)
- Hypertrophy model - WP442 (Rattus norvegicus)
- IL-5 signaling pathway - WP44 (Rattus norvegicus)
- Oxidative stress response - WP412 (Mus musculus)
- GPCRs, other - WP409 (Rattus norvegicus)
- Mitochondrial long chain fatty acid beta-oxidation - WP406 (Drosophila melanogaster)
- Oxidative damage response - WP3941 (Homo sapiens)
- Amino acid metabolism - WP3925 (Homo sapiens)
- Lipid droplet metabolism - WP3901 (Rattus norvegicus)
- Thick ascending limb transporters - WP3882 (Rattus norvegicus)
- Proximal tubule transporters - WP3881 (Rattus norvegicus)
- Toll, IMD, JAK/STAT pathways for immune response to pathogens - WP3830 (Drosophila melanogaster)
- GPCRs, class B secretin-like - WP378 (Rattus norvegicus)
- Humoral immune response to fungal and bacterial pathogens - WP3660 (Drosophila melanogaster)
- Acetylcholine synthesis - WP360 (Rattus norvegicus)
- IL-1 signaling pathway - WP355 (Rattus norvegicus)
- Regulation of actin cytoskeleton - WP351 (Rattus norvegicus)
- Synthesis and degradation of ketone bodies - WP349 (Rattus norvegicus)
- TCA cycle - WP347 (Rattus norvegicus)
- Glial cell differentiation - WP3203 (Bos taurus)
- IL-3 signaling pathway - WP319 (Rattus norvegicus)
- Striated muscle contraction - WP316 (Rattus norvegicus)
- Glucocorticoid metabolism - WP305 (Rattus norvegicus)
- Prostaglandin synthesis and regulation - WP303 (Rattus norvegicus)
- Proteasome degradation - WP302 (Rattus norvegicus)
- mir219 in oligodendrocyte differentiation and myelination - WP2811 (Rattus norvegicus)
- Proteasome degradation - WP281 (Drosophila melanogaster)
- Matrix metalloproteinases - WP278 (Rattus norvegicus)
- Heme biosynthesis - WP269 (Drosophila melanogaster)
- Chicken limb development - WP2587 (Gallus gallus)
- Sulindac metabolic pathway - WP2541 (Rattus norvegicus)
- Nuclear receptors - WP217 (Rattus norvegicus)
- Cytoplasmic ribosomal proteins - WP210 (Saccharomyces cerevisiae)
- Notch signaling pathway - WP208 (Drosophila melanogaster)
- Focal adhesion - WP188 (Rattus norvegicus)
- Proteasome degradation - WP183 (Homo sapiens)
- Oxidative stress response - WP173 (Rattus norvegicus)
- Cytoplasmic ribosomal proteins - WP163 (Mus musculus)
- Small ligand GPCRs - WP161 (Rattus norvegicus)
- Glycogen metabolism - WP160 (Rattus norvegicus)
- Proteasome degradation - WP158 (Saccharomyces cerevisiae)
- Translation factors - WP149 (Rattus norvegicus)
- Kit receptor signaling pathway - WP147 (Rattus norvegicus)
- Nucleotide metabolism - WP146 (Rattus norvegicus)
- Statin pathway - WP145 (Rattus norvegicus)
- Fatty acid omega-oxidation - WP133 (Rattus norvegicus)
- S1P receptor signal transduction - WP1312 (Rattus norvegicus)
- Mitochondrial gene expression - WP1301 (Rattus norvegicus)
- EPO receptor signaling - WP1284 (Rattus norvegicus)
- Hypothetical network for drug addiction - WP1281 (Rattus norvegicus)
- Transcriptional activation by Nfe2l2 in response to phytochemicals - WP1280 (Rattus norvegicus)
- Cytoplasmic ribosomal proteins - WP1239 (Anopheles gambiae)
- Homologous recombination - WP1205 (Drosophila melanogaster)
- FAS pathway and stress induction of HSP regulation - WP1138 (Canis familiaris)
- Apoptosis modulation by HSP70 - WP1082 (Bos taurus)
- Proteasome degradation - WP1079 (Bos taurus)
- Cytoplasmic ribosomal proteins - WP1071 (Bos taurus)
- Oxidative stress response - WP1050 (Bos taurus)
- Synthesis and degradation of ketone bodies - WP101 (Drosophila melanogaster)
- DNA replication - WP565 (Drosophila melanogaster)
- Mitochondrial long chain fatty acid beta-oxidation - WP498 (Danio rerio)
- PPAR signaling pathway - WP4020 (Danio rerio)
- Glycogen metabolism - WP1388 (Danio rerio)
- Oxidative stress response - WP1372 (Danio rerio)
- Glycolysis and gluconeogenesis - WP1356 (Danio rerio)
- Estrogen signaling - WP1330 (Danio rerio)
- Hypertrophy model - WP1327 (Danio rerio)
- MAPK signaling pathway - WP998 (Bos taurus)
- Insulin signaling - WP966 (Bos taurus)
- p38 MAPK signaling pathway - WP918 (Pan troglodytes)
- MAPK signaling pathway - WP880 (Pan troglodytes)
- p38 MAPK signaling pathway - WP803 (Gallus gallus)
- Amino acid metabolism - WP662 (Mus musculus)
- Leptin-insulin signaling overlap - WP578 (Mus musculus)
- Synthesis and degradation of ketone bodies - WP543 (Mus musculus)
- Biogenic amine synthesis - WP522 (Mus musculus)
- Acetylcholine synthesis - WP476 (Danio rerio)
- ACE inhibitor pathway - WP468 (Danio rerio)
- DNA replication - WP451 (Danio rerio)
- Insulin signaling - WP439 (Rattus norvegicus)
- ACE inhibitor pathway - WP396 (Mus musculus)
- Microglia pathogen phagocytosis pathway - WP3626 (Mus musculus)
- MAPK signaling pathway - WP358 (Rattus norvegicus)
- Target of rapamycin (TOR) signaling - WP3256 (Bos taurus)
- Cytoplasmic ribosomal proteins - WP324 (Danio rerio)
- G13 signaling pathway - WP298 (Mus musculus)
- p38 Mapk signaling pathway - WP294 (Rattus norvegicus)
- Spinal cord injury - WP2432 (Mus musculus)
- Cytokines and inflammatory response - WP222 (Mus musculus)
- Acetylcholine synthesis - WP175 (Mus musculus)
- Glycolysis and gluconeogenesis - WP157 (Mus musculus)
- MicroRNAs in cardiomyocyte hypertrophy - WP1560 (Mus musculus)
- Biogenic amine synthesis - WP154 (Danio rerio)
- Cholesterol biosynthesis - WP1387 (Danio rerio)
- Electron transport chain - WP1339 (Danio rerio)
- EPO receptor signaling - WP1336 (Danio rerio)
- Eicosanoid synthesis - WP1318 (Danio rerio)
- Insulin signaling - WP1313 (Danio rerio)
- p38 MAPK signaling pathway - WP1154 (Canis familiaris)
- Cholesterol biosynthesis - WP103 (Mus musculus)
- MAPK signaling pathway - WP1337 (Danio rerio)
- Ectoderm differentiation - WP2858 (Homo sapiens)
- Integrin-mediated cell adhesion - WP6 (Mus musculus)
- Novel Jun-Dmp1 pathway - WP3654 (Mus musculus)
- p38 Mapk signaling pathway - WP350 (Mus musculus)
- Mapk cascade - WP251 (Mus musculus)
- EPO receptor signaling - WP1249 (Mus musculus)
- Transcriptional activation by Nfe2l2 in response to phytochemicals - WP1245 (Mus musculus)
- FOXA2 pathway - WP5066 (Homo sapiens)
- Mitochondrial complex III assembly - WP4921 (Homo sapiens)
- Renin-angiotensin system - WP376 (Rattus norvegicus)
- Insulin signaling in adipocytes (diabetic condition) - WP3635 (Homo sapiens)
- Insulin signaling in adipocytes (normal condition) - WP3634 (Homo sapiens)
- Tyrobp causal network in microglia - WP3625 (Mus musculus)
- NOTCH1 regulation of endothelial cell calcification - WP3413 (Homo sapiens)
- Irinotecan pathway - WP124 (Rattus norvegicus)
- Glutathione and one-carbon metabolism - WP730 (Mus musculus)
- Host-pathogen interaction of human coronaviruses - apoptosis - WP4864 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - autophagy - WP4863 (Homo sapiens)
- One-carbon metabolism - WP435 (Mus musculus)
- Metabolism overview - WP3602 (Homo sapiens)
- Trans-sulfuration, one-carbon metabolism and related pathways - WP2525 (Homo sapiens)
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
- One-carbon metabolism and related pathways - WP1770 (Mus musculus)
- One-carbon metabolism - WP1355 (Danio rerio)
- Toll-like receptor signaling - WP88 (Mus musculus)
- Lactose degradation and galactose metabolism - WP546 (Saccharomyces cerevisiae)
- Disruption of postsynaptic signaling by CNV - WP4875 (Homo sapiens)
- Somatic sex determination - WP4814 (Homo sapiens)
- PI3K/AKT/mTOR - vitamin D3 signaling - WP4141 (Homo sapiens)
- EDA signaling in hair follicle development - WP3930 (Homo sapiens)
- BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation - WP3876 (Homo sapiens)
- Phytochrome signaling pathway to turn on photomorphogenesis - WP3662 (Arabidopsis thaliana)
- Oxytocin signaling - WP3222 (Bos taurus)
- SREBP signaling - WP3194 (Bos taurus)
- Effects of nitric oxide - WP3182 (Bos taurus)
- Farnesoid X receptor pathway - WP2879 (Homo sapiens)
- PPAR-alpha pathway - WP2878 (Homo sapiens)
- Liver X receptor pathway - WP2874 (Homo sapiens)
- Endoderm differentiation - WP2853 (Homo sapiens)
- Alzheimer's disease - WP2075 (Mus musculus)
- Nuclear receptors - WP170 (Homo sapiens)
- Selenium metabolism selenoproteins - WP1358 (Danio rerio)
- Selenium metabolism selenoproteins - WP1293 (Rattus norvegicus)
- TGF-beta signaling pathway - WP113 (Mus musculus)
- TNF-alpha signaling pathway - WP1047 (Bos taurus)